{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 1012192, "items": [{"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T17:48:07Z", "timestamp": 1575308887422}, "reference-count": 0, "publisher": "Ferrata Storti Foundation (Haematologica)", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Haematologica"], "published-print": {"date-parts": [[2008, 12, 1]]}, "DOI": "10.3324/haematol.13192", "type": "journal-article", "created": {"date-parts": [[2008, 9, 25]], "date-time": "2008-09-25T00:26:38Z", "timestamp": 1222302398000}, "page": "1903-1907", "source": "Crossref", "is-referenced-by-count": 14, "title": ["EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22"], "prefix": "10.3324", "volume": "93", "author": [{"given": "A.", "family": "De Weer", "sequence": "first", "affiliation": []}, {"given": "F.", "family": "Speleman", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Cauwelier", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Van Roy", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Yigit", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Verhasselt", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "De Moerloose", "sequence": "additional", "affiliation": []}, {"given": "Y.", "family": "Benoit", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Noens", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Selleslag", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Lippert", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Struski", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Bastard", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "De Paepe", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Vandenberghe", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Hagemeijer", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Dastugue", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Poppe", "sequence": "additional", "affiliation": []}, {"name": "on behalf of the Groupe Francais de Cytogenetique Hematologique (GFCH)", "sequence": "additional", "affiliation": []}], "member": "1856", "published-online": {"date-parts": [[2008, 9, 24]]}, "container-title": ["Haematologica"], "language": "en", "deposited": {"date-parts": [[2011, 7, 12]], "date-time": "2011-07-12T14:09:53Z", "timestamp": 1310479793000}, "score": 83.92918, "issued": {"date-parts": [[2008, 9, 24]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2008, 12, 2]]}, "published-print": {"date-parts": [[2008, 12, 1]]}, "issue": "12"}, "URL": "http://dx.doi.org/10.3324/haematol.13192", "ISSN": ["0390-6078", "1592-8721"], "issn-type": [{"value": "0390-6078", "type": "print"}, {"value": "1592-8721", "type": "electronic"}], "subject": ["Hematology"]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:36:06Z", "timestamp": 1575531366448}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "11", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2007, 11, 16]]}, "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>Chromosomal rearrangements involving the EVI1 gene are a recurrent finding in malignant myeloid disorders. These translocations or inversions contribute to ectopic expression of, or to the formation of fusion genes involving the EVI1 gene. EVI1 transcriptional activation has been reported in up to 10% of acute myeloid leukemia (AML) patients, and is a diagnostic marker which predicts a poor outcome. Recently, microRNA deregulation was identified as a major contributor to cancer initiation and progression. Moreover, miRNA genes were shown to be directly regulated by activated proto-oncogenes. In this study, we investigated which miRNA genes are implicated in the transcriptional pathways governed by the EVI1 oncogene. A total of 384 miRNAs were profiled through automated qRT-PCR using high-throughput quantitative stem-loop RT-PCR (Applied Biosystems). In a first step, differential miRNA expression was determined in 5 EVI1 rearranged/EVI1 overexpressing samples, 5 non-rearranged/EVI1 overexpressing samples and 5 non-rearranged/non-EVI1 overexpressing bone marrow samples. Next, up and down regulated miRNAs were analyzed in the leukemic EVI1 overexpressing cell lines Kasumi-3 and UCSD-AML1 following transient EVI1 RNAi knockdown. We will present the detailed results of these profiling studies as well as the results of data mining for identification of putative EVI1 regulated miRNAs. Further functional studies will be performed in order to select validated miRNA target genes and to asses their contribution to the leukemic phenotype. We anticipate that the discovery of such miRNAs may provide new targets for therapeutic intervention.</jats:p>", "DOI": "10.1182/blood.v110.11.4146.4146", "type": "journal-article", "created": {"date-parts": [[2019, 10, 14]], "date-time": "2019-10-14T15:18:13Z", "timestamp": 1571066293000}, "page": "4146-4146", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 0, "title": ["MicroRNA Profiling of EVI1 Deregulated Myeloid Leukemia."], "prefix": "10.1182", "volume": "110", "author": [{"given": "An", "family": "De Weer", "sequence": "first", "affiliation": [{"name": "Center for Medical Genetics Gent, Ghent University Hospital, Ghent, Belgium"}, {"name": "(Intr. by Bart Vandekerckhove)"}]}, {"given": "Bruce", "family": "Poppe", "sequence": "additional", "affiliation": [{"name": "Center for Medical Genetics Gent, Ghent University Hospital, Ghent, Belgium"}, {"name": "(Intr. by Bart Vandekerckhove)"}]}, {"given": "Pieter", "family": "Mestdagh", "sequence": "additional", "affiliation": [{"name": "Center for Medical Genetics Gent, Ghent University Hospital, Ghent, Belgium"}, {"name": "(Intr. by Bart Vandekerckhove)"}]}, {"given": "Nadine", "family": "Van Roy", "sequence": "additional", "affiliation": [{"name": "Center for Medical Genetics Gent, Ghent University Hospital, Ghent, Belgium"}, {"name": "(Intr. by Bart Vandekerckhove)"}]}, {"given": "Anne", "family": "De Paepe", "sequence": "additional", "affiliation": [{"name": "Center for Medical Genetics Gent, Ghent University Hospital, Ghent, Belgium"}, {"name": "(Intr. by Bart Vandekerckhove)"}]}, {"given": "Bruno", "family": "Verhasselt", "sequence": "additional", "affiliation": [{"name": "Department of Clinical Chemistry, Microbiology and Immunology, Center for Molecular Diagnostics, Ghent University Hospital, Ghent, Belgium"}, {"name": "(Intr. by Bart Vandekerckhove)"}]}, {"given": "Jo", "family": "Vandesompele", "sequence": "additional", "affiliation": [{"name": "Center for Medical Genetics Gent, Ghent University Hospital, Ghent, Belgium"}, {"name": "(Intr. by Bart Vandekerckhove)"}]}, {"given": "Frank", "family": "Speleman", "sequence": "additional", "affiliation": [{"name": "Center for Medical Genetics Gent, Ghent University Hospital, Ghent, Belgium"}, {"name": "(Intr. by Bart Vandekerckhove)"}]}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "https://ashpublications.org/blood/article/110/11/4146/83941/MicroRNA-Profiling-of-EVI1-Deregulated-Myeloid", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "https://ashpublications.org/blood/article/110/11/4146/83941/MicroRNA-Profiling-of-EVI1-Deregulated-Myeloid", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T16:37:11Z", "timestamp": 1574095031000}, "score": 40.949486, "issued": {"date-parts": [[2007, 11, 16]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2007, 11, 16]]}, "issue": "11"}, "URL": "http://dx.doi.org/10.1182/blood.v110.11.4146.4146", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T16:04:04Z", "timestamp": 1576857844228}, "reference-count": 35, "publisher": "American Society of Hematology", "issue": "8", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2008, 4, 15]]}, "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>Inappropriate expression of EVI1 (ecotropic virus integration-1), in particular splice form EVI1-1D, through chromosome 3q26 lesions or other mechanisms has been implicated in the development of high-risk acute myeloid leukemia (AML). To validate the clinical relevance of EVI1-1D, as well as of the other EVI1 splice forms and the related MDS1/EVI1 (ME) gene, real-time quantitative polymerase chain reaction was performed in 534 untreated adults with de novo AML. EVI1-1D was highly expressed in 6% of cases (n = 32), whereas 7.8% were EVI1+ (n = 41) when all splice variants were taken into account. High EVI1 predicted a distinctly worse event-free survival (HR = 1.9; P = .002) and disease-free survival (HR = 2.1, P = .006) following multivariate analysis. Importantly, we distinguished a subset of EVI1+ cases that lacked expression of ME (EVI1+ME\u2212; n = 17) from cases that were ME+ (EVI1+ME+; n = 24). The atypical EVI1+ME\u2212 expression pattern exhibited cytogenetically detectable chromosomal 3q26 breakpoints in 8 cases. Fluorescence in situ hybridization revealed 7 more EVI1+ME\u2212 cases that carried cryptic 3q26 breakpoints, which were not found in the EVI1+ME+ group. EVI1+ME\u2212 expression predicts an extremely poor prognosis distinguishable from the general EVI1+ AML patients (overall survival [OS]: P &lt; .001 and event-free survival [EFS]: P = .002). We argue that EVI1/ME quantitative expression analysis should be implemented in the molecular diagnostic procedures of AML.</jats:p>", "DOI": "10.1182/blood-2007-10-119230", "type": "journal-article", "created": {"date-parts": [[2008, 2, 14]], "date-time": "2008-02-14T02:25:06Z", "timestamp": 1202955906000}, "page": "4329-4337", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 166, "title": ["High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated"], "prefix": "10.1182", "volume": "111", "author": [{"given": "Sanne", "family": "Lugthart", "sequence": "first", "affiliation": [{"name": "Departments ofHematology,"}]}, {"given": "Ellen", "family": "van Drunen", "sequence": "additional", "affiliation": [{"name": "Clinical Genetics, and"}]}, {"given": "Yvette", "family": "van Norden", "sequence": "additional", "affiliation": [{"name": "Trials and Statistics, Erasmus University Medical Center, Rotterdam, The Netherlands"}]}, {"given": "Antoinette", "family": "van Hoven", "sequence": "additional", "affiliation": [{"name": "Departments ofHematology,"}]}, {"given": "Claudia A. J.", "family": "Erpelinck", "sequence": "additional", "affiliation": [{"name": "Departments ofHematology,"}]}, {"given": "Peter J. M.", "family": "Valk", "sequence": "additional", "affiliation": [{"name": "Departments ofHematology,"}]}, {"given": "H. Berna", "family": "Beverloo", "sequence": "additional", "affiliation": [{"name": "Clinical Genetics, and"}]}, {"given": "Bob", "family": "L\u00f6wenberg", "sequence": "additional", "affiliation": [{"name": "Departments ofHematology,"}]}, {"given": "Ruud", "family": "Delwel", "sequence": "additional", "affiliation": [{"name": "Departments ofHematology,"}]}], "member": "234", "reference": [{"key": "2019111712594257500_B1", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.gene.2005.09.020", "article-title": "EVI1 and hematopoietic disorders: history and perspectives.", "volume": "368", "author": "Nucifora", "year": "2006", "journal-title": "Gene"}, {"key": "2019111712594257500_B2", "doi-asserted-by": "crossref", "first-page": "3937", "DOI": "10.1073/pnas.89.9.3937", "article-title": "Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26.", "volume": "89", "author": "Morishita", "year": "1992", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "2019111712594257500_B3", "doi-asserted-by": "crossref", "first-page": "837", "DOI": "10.1182/blood-2002-05-1459", "article-title": "High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients.", "volume": "101", "author": "Barjesteh van Waalwijk van Doorn-Khosrovani", "year": "2003", "journal-title": "Blood"}, {"key": "2019111712594257500_B4", "doi-asserted-by": "crossref", "first-page": "80", "DOI": "10.1002/gcc.10144", "article-title": "Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia.", "volume": "36", "author": "Vinatzer", "year": "2003", "journal-title": "Genes Chromosomes Cancer"}, {"key": "2019111712594257500_B5", "doi-asserted-by": "crossref", "first-page": "160", "DOI": "10.1016/j.gene.2005.04.032", "article-title": "Regulation of the expression of the oncogene EVI1 through the use of alternative mRNA 5\u2032-ends.", "volume": "356", "author": "Aytekin", "year": "2005", "journal-title": "Gene"}, {"key": "2019111712594257500_B6", "doi-asserted-by": "crossref", "first-page": "1642", "DOI": "10.1073/pnas.93.4.1642", "article-title": "Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.", "volume": "93", "author": "Fears", "year": "1996", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "2019111712594257500_B7", "doi-asserted-by": "crossref", "first-page": "2045", "DOI": "10.1038/sj.leu.2400865", "article-title": "EVI-1 gene expression in myeloid clonogenic cells from juvenile myelomonocytic leukemia (JMML).", "volume": "11", "author": "Privitera", "year": "1997", "journal-title": "Leukemia"}, {"key": "2019111712594257500_B8", "doi-asserted-by": "crossref", "first-page": "882", "DOI": "10.1046/j.1365-2141.1997.4983304.x", "article-title": "Expression of the Evi-1 gene in haemopoietic cells of children with juvenile myelomonocytic leukaemia and normal donors.", "volume": "99", "author": "Gerhardt", "year": "1997", "journal-title": "Br J Haematol"}, {"key": "2019111712594257500_B9", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1002/gcc.20295", "article-title": "EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements.", "volume": "45", "author": "Poppe", "year": "2006", "journal-title": "Genes Chromosomes Cancer"}, {"key": "2019111712594257500_B10", "doi-asserted-by": "crossref", "first-page": "3496", "DOI": "10.1200/JCO.1997.15.12.3496", "article-title": "Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.", "volume": "15", "author": "Lowenberg", "year": "1997", "journal-title": "J Clin Oncol"}, {"key": "2019111712594257500_B11", "doi-asserted-by": "crossref", "first-page": "743", "DOI": "10.1056/NEJMoa025406", "article-title": "Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.", "volume": "349", "author": "Lowenberg", "year": "2003", "journal-title": "N Engl J Med"}, {"key": "2019111712594257500_B12", "doi-asserted-by": "crossref", "first-page": "2908", "DOI": "10.1182/blood-2003-07-2195", "article-title": "The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients.", "volume": "103", "author": "Ossenkoppele", "year": "2004", "journal-title": "Blood"}, {"key": "2019111712594257500_B13", "doi-asserted-by": "crossref", "first-page": "1617", "DOI": "10.1056/NEJMoa040465", "article-title": "Prognostically useful gene-expression profiles in acute myeloid leukemia.", "volume": "350", "author": "Valk", "year": "2004", "journal-title": "N Engl J Med"}, {"key": "2019111712594257500_B14", "first-page": "106", "article-title": "Second hit mutations in the RTK/RAS signalling pathway in acute myeloid leukaemia and inv(16) [letter].", "volume": "89", "author": "Valk", "year": "2004", "journal-title": "Haematologica"}, {"key": "2019111712594257500_B15", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1038/sj.thj.6200216", "article-title": "Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML.", "volume": "4", "author": "van Waalwijk van Doorn-Khosrovani", "year": "2003", "journal-title": "Hematol J"}, {"key": "2019111712594257500_B16", "doi-asserted-by": "crossref", "first-page": "775", "DOI": "10.1046/j.1365-2141.2003.04362.x", "article-title": "Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias.", "volume": "121", "author": "Care", "year": "2003", "journal-title": "Br J Haematol"}, {"key": "2019111712594257500_B17", "doi-asserted-by": "crossref", "first-page": "3747", "DOI": "10.1182/blood-2005-05-2168", "article-title": "Mutations in nucleophosmin NPM1 in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance.", "volume": "106", "author": "Verhaak", "year": "2005", "journal-title": "Blood"}, {"key": "2019111712594257500_B18", "doi-asserted-by": "crossref", "first-page": "402", "DOI": "10.1006/meth.2001.1262", "article-title": "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method.", "volume": "25", "author": "Livak", "year": "2001", "journal-title": "Methods"}, {"key": "2019111712594257500_B19", "doi-asserted-by": "crossref", "first-page": "731", "DOI": "10.1002/gcc.20335", "article-title": "High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9.", "volume": "45", "author": "von Bergh", "year": "2006", "journal-title": "Genes Chromosomes Cancer"}, {"key": "2019111712594257500_B20", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1080/01621459.1958.10501452", "article-title": "Nonparametric estimation from incomplete observations.", "volume": "53", "author": "Meier", "year": "1958", "journal-title": "J Am Stat Assoc"}, {"key": "2019111712594257500_B21", "first-page": "187", "article-title": "Regression models and life-tables.", "volume": "34", "author": "Cox", "year": "1972", "journal-title": "J Royal Stat Soc B"}, {"key": "2019111712594257500_B22", "doi-asserted-by": "crossref", "first-page": "3658", "DOI": "10.1182/blood-2006-06-025627", "article-title": "Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?", "volume": "109", "author": "Cornelissen", "year": "2007", "journal-title": "Blood"}, {"key": "2019111712594257500_B23", "doi-asserted-by": "crossref", "first-page": "504", "DOI": "10.1002/j.1460-2075.1994.tb06288.x", "article-title": "Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia.", "volume": "13", "author": "Mitani", "year": "1994", "journal-title": "Embo J"}, {"key": "2019111712594257500_B24", "doi-asserted-by": "crossref", "first-page": "1613", "DOI": "10.1182/blood-2003-02-0359", "article-title": "BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study.", "volume": "102", "author": "Baldus", "year": "2003", "journal-title": "Blood"}, {"key": "2019111712594257500_B25", "doi-asserted-by": "crossref", "first-page": "3337", "DOI": "10.1200/JCO.2007.10.8720", "article-title": "High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.", "volume": "25", "author": "Marcucci", "year": "2007", "journal-title": "J Clin Oncol"}, {"key": "2019111712594257500_B26", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1016/j.cancergencyto.2007.05.003", "article-title": "Feasibility of using the combined MDS-EVI1/EVI1 gene expression as an alternative molecular marker in acute myeloid leukemia: a report of four cases.", "volume": "177", "author": "Weisser", "year": "2007", "journal-title": "Cancer Genet Cytogenet"}, {"key": "2019111712594257500_B27", "doi-asserted-by": "crossref", "first-page": "643", "DOI": "10.1038/sj.leu.2402859", "article-title": "A discriminating screening is necessary to ascertain EVI1 expression by RT-PCR in malignant cells from the myeloid lineage without 3q26 rearrangement.", "volume": "17", "author": "Zoccola", "year": "2003", "journal-title": "Leukemia"}, {"key": "2019111712594257500_B28", "doi-asserted-by": "crossref", "first-page": "346", "DOI": "10.1016/j.gene.2007.04.012", "article-title": "The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions.", "volume": "396", "author": "Wieser", "year": "2007", "journal-title": "Gene"}, {"key": "2019111712594257500_B29", "doi-asserted-by": "crossref", "first-page": "4090", "DOI": "10.1182/blood-2005-09-3778", "article-title": "Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas.", "volume": "107", "author": "Tam", "year": "2006", "journal-title": "Blood"}, {"key": "2019111712594257500_B30", "author": "Kumar", "volume": "108", "year": "2006", "article-title": "Differential expression of Mll-AF9 up-regulated genes correlates with enhanced self-renewal of hematopoietic progenitors.", "journal-title": "Blood"}, {"key": "2019111712594257500_B31", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1182/blood-2005-01-0204", "article-title": "The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.", "volume": "106", "author": "Whitman", "year": "2005", "journal-title": "Blood"}, {"key": "2019111712594257500_B32", "doi-asserted-by": "crossref", "first-page": "44936", "DOI": "10.1074/jbc.M106733200", "article-title": "Interaction of EVI1 with cAMP-responsive element-binding protein-binding protein (CBP) and p300/CBP-associated factor (P/CAF) results in reversible acetylation of EVI1 and in co-localization in nuclear speckles.", "volume": "276", "author": "Chakraborty", "year": "2001", "journal-title": "J Biol Chem"}, {"key": "2019111712594257500_B33", "doi-asserted-by": "crossref", "first-page": "566", "DOI": "10.1046/j.1365-2141.2001.02987.x", "article-title": "The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase.", "volume": "114", "author": "Vinatzer", "year": "2001", "journal-title": "Br J Haematol"}, {"key": "2019111712594257500_B34", "doi-asserted-by": "crossref", "first-page": "4003", "DOI": "10.1182/blood.V92.11.4003", "article-title": "The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.", "volume": "92", "author": "Kurokawa", "year": "1998", "journal-title": "Blood"}, {"key": "2019111712594257500_B35", "doi-asserted-by": "crossref", "first-page": "7658", "DOI": "10.1128/MCB.00363-06", "article-title": "Point mutations in two EVI1 Zn fingers abolish EVI1-GATA1 interaction and allow erythroid differentiation of murine bone marrow cells.", "volume": "26", "author": "Laricchia-Robbio", "year": "2006", "journal-title": "Mol Cell Biol"}], "container-title": ["Blood"], "language": "en", "link": [{"URL": "http://ashpublications.org/blood/article-pdf/111/8/4329/1299412/zh800808004329.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/blood/article-pdf/111/8/4329/1299412/zh800808004329.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 17]], "date-time": "2019-11-17T17:59:58Z", "timestamp": 1574013598000}, "score": 39.271584, "issued": {"date-parts": [[2008, 4, 15]]}, "references-count": 35, "journal-issue": {"published-print": {"date-parts": [[2008, 4, 15]]}, "issue": "8"}, "URL": "http://dx.doi.org/10.1182/blood-2007-10-119230", "relation": {"cites": []}, "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T14:45:21Z", "timestamp": 1574433921756}, "publisher-location": "Berlin, Heidelberg", "reference-count": 63, "publisher": "Springer Berlin Heidelberg", "isbn-type": [{"value": "9783642852343", "type": "print"}, {"value": "9783642852329", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1996]]}, "DOI": "10.1007/978-3-642-85232-9_21", "type": "book-chapter", "created": {"date-parts": [[2011, 12, 15]], "date-time": "2011-12-15T15:17:04Z", "timestamp": 1323962224000}, "page": "211-222", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Molecular Analysis of Evi1, a Zinc Finger Oncogene Involved in Myeloid Leukemia"], "prefix": "10.1007", "author": [{"given": "M. C.", "family": "Lopingco", "sequence": "first", "affiliation": []}, {"given": "A. S.", "family": "Perkins", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "21_CR1", "first-page": "586", "volume": "51", "author": "H Bedigian", "year": "1984", "unstructured": "Bedigian H, Johnson D, Jenkins N, Copeland N, Evans R (1984) Spontaneous and induced leukemias of myeloid origin in recombinant inbred BXH mice. J Virol 51:586\u2013594", "journal-title": "J Virol"}, {"key": "21_CR2", "doi-asserted-by": "crossref", "first-page": "4236", "DOI": "10.1128/MCB.6.12.4236", "volume": "6", "author": "ML Mucenski", "year": "1986", "unstructured": "Mucenski ML, Taylor BA, Jenkins NA, Copeland NG (1986) AKXD recombinant inbred strains: Models for studying the molecular genetic basis of murine lymphomas. Mol Cell Biol 6:4236\u20134243", "journal-title": "Mol Cell Biol"}, {"key": "21_CR3", "doi-asserted-by": "publisher", "first-page": "831", "DOI": "10.1016/S0092-8674(88)91175-0", "volume": "54", "author": "K Morishita", "year": "1988", "unstructured": "Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NGJhle JN (1988) Retroviral activation of a novel gene encoding a zinc finger protein in IL3-dependent myeloid leukemia cell lines. Cell 54:831\u2013840", "journal-title": "Cell"}, {"key": "21_CR4", "doi-asserted-by": "crossref", "first-page": "4658", "DOI": "10.1128/MCB.10.9.4658", "volume": "10", "author": "AM Buchberg", "year": "1990", "unstructured": "Buchberg AM, Bedigian HG, Jenkins NA, Copeland NG (1990) Evi-2, a common integration site, involved in murine myeloid leukemogenesis. Mol Cell Biol 10:4658\u20134666", "journal-title": "Mol Cell Biol"}, {"key": "21_CR5", "doi-asserted-by": "publisher", "first-page": "1332", "DOI": "10.1073/pnas.87.4.1332", "volume": "87", "author": "Y Ben-David", "year": "1990", "unstructured": "Ben-David Y, Giddens EB, Bernstein A (1990) Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. pnas 87:1332\u20131336", "journal-title": "pnas"}, {"key": "21_CR6", "doi-asserted-by": "publisher", "first-page": "277", "DOI": "10.1038/331277a0", "volume": "331", "author": "F Moreau-Gachelin", "year": "1988", "unstructured": "Moreau-Gachelin F, Tavitian A, Tambourin P (1988) Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature 331:277\u2013280", "journal-title": "Nature"}, {"key": "21_CR7", "doi-asserted-by": "crossref", "first-page": "554", "DOI": "10.1128/MCB.11.1.554", "volume": "11", "author": "D Aberdam", "year": "1991", "unstructured": "Aberdam D, Negreanu V, Sachs L, Blatt C (1991) The oncogenic potential of an activated hcrx-2.4 homeobox gene in mouse fibrolasts. Mol Cell Biol 11:554\u2013557", "journal-title": "Mol Cell Biol"}, {"key": "21_CR8", "author": "J Moskow", "year": "1995", "unstructured": "Moskow J, Bullrich F, Huebner K, Buchberg A (1995) Personal communication.", "volume-title": "Personal communication"}, {"key": "21_CR9", "author": "T Nakamura", "year": "1995", "unstructured": "Nakamura T, Copeland N (1995) personal communication", "volume-title": "personal communication"}, {"key": "21_CR10", "doi-asserted-by": "crossref", "first-page": "301", "DOI": "10.1128/MCB.8.1.301", "volume": "8", "author": "ML Mucenski", "year": "1988", "unstructured": "Mucenski ML, Taylor BA, Ihle JN, Hartley JW, Morse III HC, Jenkins NA, Copeland NG (1988) Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors. Mol Cell Biol 8:301\u2013308", "journal-title": "Mol Cell Biol"}, {"key": "21_CR11", "doi-asserted-by": "publisher", "first-page": "661", "DOI": "10.1016/0042-6822(92)90241-G", "volume": "191", "author": "D Bergeron", "year": "1992", "unstructured": "Bergeron D, Poliquin L, Houde J, Barbeau B, Rassart E (1992) Analysis of proviruses integrated in Fli-1 and Evi-1 regions in Cas-Br-E MuLV-induced non-T-, non-B-cell leukemias. Virology 191:661\u2013669", "journal-title": "Virology"}, {"key": "21_CR12", "doi-asserted-by": "crossref", "first-page": "1259", "DOI": "10.1128/MCB.10.3.1259", "volume": "10", "author": "T Matsugi", "year": "1990", "unstructured": "Matsugi T, Morishita K, Ihle JN (1990) Identification, nuclear localization, and DNA-binding activity of the zinc finger protein encoded by the Evi-1 myeloid transforming gene. Mol Cell Biol 10:1259\u20131264", "journal-title": "Mol Cell Biol"}, {"key": "21_CR13", "first-page": "4043", "volume": "61", "author": "D Bordereaux", "year": "1987", "unstructured": "Bordereaux D, Fichelson S, Sola B, Tambourin PE, Gisselbrecht S (1987) Frequent involvement of the fim-3 region in Friend murine leukemia virus-induced mouse myeloblastic leukemias. J Virol 61:4043\u20134045", "journal-title": "J Virol"}, {"key": "21_CR14", "first-page": "529", "volume": "4", "author": "C Bartholomew", "year": "1989", "unstructured": "Bartholomew C, Morishita K, Askew D, Buchberg D, Jenkins NA, Copeland NG, Ihle JN (1989) Retroviral insertions in the CB-1/ Fim-3 common site of integration active expression of the Evi-l gene. Oncogene 4:529\u2013534", "journal-title": "Oncogene"}, {"key": "21_CR15", "doi-asserted-by": "crossref", "first-page": "1820", "DOI": "10.1128/MCB.11.4.1820", "volume": "11", "author": "C Bartholomew", "year": "1991", "unstructured": "Bartholomew C, Ihle J (1991) Retroviral insertions 90 kilobases proximal to the Evi-l myeloid transforming gene activate transcription from the normal promoter. Mol Cell Biol 11:1820\u20131828", "journal-title": "Mol Cell Biol"}, {"key": "21_CR16", "doi-asserted-by": "publisher", "first-page": "3937", "DOI": "10.1073/pnas.89.9.3937", "volume": "89", "author": "K Morishita", "year": "1992", "unstructured": "Morishita K, Parganas E, Willman CL, Whittaker MH, Drabkin H, Oval J, Taetle R, Valentine MB, Ihle JN (1992) Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300\u2013400 kilobases on chromosome band 3q26. Proc Natl Acad Sci USA 89:3937\u20133941", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "21_CR17", "first-page": "446", "volume": "6", "author": "J Oval", "year": "1992", "unstructured": "Oval J, Smedsrud M, Taetle R (1992) Expression and regulation of the Evi-l gene in the human factor-dependent leukemia cell line, UCSD/AML1. Leukemia 6:446\u2013451", "journal-title": "Leukemia"}, {"key": "21_CR18", "first-page": "93", "volume": "6", "author": "S Fichelson", "year": "1992", "unstructured": "Fichelson S, Dreyfus F, Berger R, Melle J, Bastard C, Miclea J, Gisselbrecht S (1992) Evi-l expression in leukemic patients with rearrangements of the 3Q25-Q28 chromosomal region. Leukemia 6:93\u201399", "journal-title": "Leukemia"}, {"key": "21_CR19", "doi-asserted-by": "publisher", "first-page": "4004", "DOI": "10.1073/pnas.91.9.4004", "volume": "91", "author": "G Nucifora", "year": "1994", "unstructured": "Nucifora G, Begy CR, Kobayashi H, Roulston D, Claxton d, Pedersen-Bjergaard J, Parganas E, Ihle JN, Rowley JD (1994) Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc Nat\u2019l Acad Sci USA 91:4004\u20134008", "journal-title": "Proc Nat\u2019l Acad Sci USA"}, {"key": "21_CR20", "first-page": "1348", "volume": "83", "author": "ER Levy", "year": "1994", "unstructured": "Levy ER, Parganas E, Morishita K, Fichelson S, James L, Oscier D, Gisselbrecht S, Ihle JN, Buckle VJ (1994) DNA rearrangements proximal to the EVI1 locus associated with the 3q21q26 syndrome. Blood 83:1348\u20131354", "journal-title": "Blood"}, {"key": "21_CR21", "first-page": "2681", "volume": "84", "author": "K Suzukawa", "year": "1994", "unstructured": "Suzukawa K, Parganas E, Gajjar A, Abe T, Takahashi S, Tani K, Asano S, Asou H, Kamada N, Yokota J, Morishita K, Ihle JN (1994) Identification of a breakpoint cluster region 3\u2019 of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26). Blood 84:2681\u20132688", "journal-title": "Blood"}, {"key": "21_CR22", "doi-asserted-by": "crossref", "first-page": "504", "DOI": "10.1002/j.1460-2075.1994.tb06288.x", "volume": "13", "author": "K Mitani", "year": "1994", "unstructured": "Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Ohki M, Hirai H (1994) Generation of the AML1 - EVI-1 fusion gene in the t(3;21)(126;q22) causes blastic crisis in chronic myelocytic leukemia. The EMBO Journal 13:504\u2013510", "journal-title": "The EMBO Journal"}, {"key": "21_CR23", "first-page": "221", "volume": "5", "author": "K Morishita", "year": "1990", "unstructured": "Morishita K, Parganas E, Bartholomew C, Sacchi N, Valentine MC, Raimondi SC, Le Beau MMJhle JN (1990) The human Evi-1 gene is located on chromosome 3q24-q28 but is not rearranged in three cases of acute nonlymphocytic leukemias containing t(3;5) (q25;q34) translocations. Oncogene Research 5:221\u2013231", "journal-title": "Oncogene Research"}, {"key": "21_CR24", "doi-asserted-by": "publisher", "first-page": "535", "DOI": "10.1002/1097-0142(19850201)55:3<535::AID-CNCR2820550311>3.0.CO;2-4", "volume": "55", "author": "T Pintado", "year": "1985", "unstructured": "Pintado T, Ferro M, San Roman C, Mayayo M, Larana J (1985) Clinical correlations of the 3q21;3q26 cytogenetic anomaly. A leukemic or myelodysplastic syndrome with preserved or increased platelet production and lack of response to cytotoxic drug therapy. Cancer 55:535\u2013541", "journal-title": "Cancer"}, {"key": "21_CR25", "first-page": "1362", "volume": "66", "author": "M Bitter", "year": "1985", "unstructured": "Bitter M, Neilly M, LeBeau M, Pearson M, Rowley J (1985) Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute non-lymphocytic leukemia. Blood 66:1362\u20131370", "journal-title": "Blood"}, {"key": "21_CR26", "doi-asserted-by": "publisher", "first-page": "138", "DOI": "10.1016/0165-4608(92)90208-P", "volume": "59", "author": "M Bellomo", "year": "1992", "unstructured": "Bellomo M, Parlier V, Muhlematter D, Grob J, Beris P (1992) Three new cases of chromosome 3 rearrangements in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q213q26 syndrome. Cancer Genet Cytogenet 59:138", "journal-title": "Cancer Genet Cytogenet"}, {"key": "21_CR27", "first-page": "256", "volume": "34", "author": "N Schneider", "year": "1991", "unstructured": "Schneider N, Bowman WJ, Frenkel E (1991) Translocation (3;21)(q26;q22) in secondary leukemia. Ann Genet 34:256\u2013263", "journal-title": "Ann Genet"}, {"key": "21_CR28", "first-page": "2594", "volume": "76", "author": "C Rubin", "year": "1990", "unstructured": "Rubin C, Larson R, Anastasi J, Winter J, Thangavelu M, Vardiman J, Rowley J, LeBeau M (1990) t(3;21)(q26;q22): A recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 76:2594\u20132598", "journal-title": "Blood"}, {"key": "21_CR29", "doi-asserted-by": "publisher", "first-page": "56", "DOI": "10.1002/ajh.2830270113", "volume": "27", "author": "T Coyle", "year": "1988", "unstructured": "Coyle T, Najfeld V (1988) Tranlocation (3;21) in Philadelphia chromosome-positive chromic myelogenous leukemia prior to the onset of blast crisis. Am J Hematol 27:56\u201359", "journal-title": "Am J Hematol"}, {"key": "21_CR30", "first-page": "1338", "volume": "70", "author": "C Rubin", "year": "1987", "unstructured": "Rubin C, Larson R, Bitter M, Carrino J, LeBeau M, Diaz M, Rowley J (1987) Association of a chromosomal 3;21 translocation with the blast phase of chronic myelogenous leukemia. Blood 70:1338\u20131342", "journal-title": "Blood"}, {"key": "21_CR31", "doi-asserted-by": "publisher", "first-page": "338", "DOI": "10.1016/0168-9525(93)90026-E", "volume": "9", "author": "H Kagoshima", "year": "1993", "unstructured": "Kagoshima H, Shigesada K, Satake M, Ito Y, Miyoshi H, Ohki M, Pepling M, Gergen P (1993) The Runt domain identifies a new family of heteromeric trasncriptional regulators. Trends in Genetics 9:338\u2013341", "journal-title": "Trends in Genetics"}, {"key": "21_CR32", "doi-asserted-by": "publisher", "first-page": "10431", "DOI": "10.1073/pnas.88.23.10431", "volume": "88", "author": "H Miyoshi", "year": "1991", "unstructured": "Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y (1991) t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1 Proc. Natl. Acad. Sci. USA 88:10431\u201310434", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "21_CR33", "doi-asserted-by": "publisher", "first-page": "7784", "DOI": "10.1073/pnas.90.16.7784", "volume": "90", "author": "G Nucifora", "year": "1993", "unstructured": "Nucifora G, Begy CR, Erickson P, Drabkin HA, Rowley JA (1993) The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1. Proc. Natl. Acad. Sci. USA 90:7784\u20137788", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "21_CR34", "first-page": "963", "volume": "5", "author": "K Morishita", "year": "1990", "unstructured": "Morishita K, Parganas E, Douglass EC, Ihle JN (1990) Unique expression of the human Evi-l gene in an endometrial carcinoma cell line: Sequence of cDNAs and structure of alternatively spliced transcripts. Oncogene 5:963\u2013971", "journal-title": "Oncogene"}, {"key": "21_CR35", "first-page": "925", "volume": "5", "author": "D Bordereaux", "year": "1990", "unstructured": "Bordereaux D, Fichelson S, Tambourin P, Gisselbrecht S (1990) Alternative splicing of the Evi-1 zinc finger gene generates mRNAs which differ by the number of zinc finger motifs. Oncogene 5:925\u2013927", "journal-title": "Oncogene"}, {"key": "21_CR36", "doi-asserted-by": "crossref", "first-page": "4291", "DOI": "10.1128/MCB.13.7.4291", "volume": "13", "author": "R Delwel", "year": "1993", "unstructured": "Delwel R, Funabiki T, Kreider B, Morishita K, Ihle J (1993) Four of the seven zinc fingers of the Evi-1 myeloid transforming gene are required for sequence-specific binding to GA(C/T)AAGA(T/C)AAGATAA. Mol Cell Biol 13:4291\u20134300", "journal-title": "Mol Cell Biol"}, {"key": "21_CR37", "author": "A Khanna-Gupta", "year": "1995", "unstructured": "Khanna-Gupta A, Savinelli T, Berliner N, Perkins A (1995) Retroviral insertional activation of the Evil oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line, 32Dcl3. Submitted", "volume-title": "Retroviral insertional activation of the Evil oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line, 32Dcl3"}, {"key": "21_CR38", "doi-asserted-by": "publisher", "first-page": "333", "DOI": "10.1016/0092-8674(94)90340-9", "volume": "76", "author": "J Dyck", "year": "1994", "unstructured": "Dyck J, Maul G, Miller W, Chen J, Kakizuka A, Evans R (1994) A novel macromolecular structure is a target of the promyelocyte-receptor oncoprotein. Cell 76:333\u2013343", "journal-title": "Cell"}, {"key": "21_CR39", "doi-asserted-by": "publisher", "first-page": "345", "DOI": "10.1016/0092-8674(94)90341-7", "volume": "76", "author": "K Weis", "year": "1994", "unstructured": "Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonesca M, Lamond A, Dejean A (1994) Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic cells. Cell 76:345\u2013356", "journal-title": "Cell"}, {"key": "21_CR40", "doi-asserted-by": "publisher", "first-page": "125", "DOI": "10.1016/0092-8674(88)90015-3", "volume": "55", "author": "SP Jackson", "year": "1988", "unstructured": "Jackson SP, Tjian R (1988) O-glycosylation of eukaryotic transcription factors: Implications for mechanism of transcriptional regulation. Cell 55:125\u2013133", "journal-title": "Cell"}, {"key": "21_CR41", "first-page": "479", "volume": "111", "author": "AS Perkins", "year": "1991", "unstructured": "Perkins AS, Mercer J A, Jenkins NA, Copeland NG (1991) Patterns of Evi-1 expression in embryonic and adult tissues suggest that Evi-1 plays an important role in mouse development. Development 111:479\u2013487", "journal-title": "Development"}, {"key": "21_CR42", "first-page": "939", "volume": "9", "author": "C Bartholomew", "year": "1994", "unstructured": "Bartholomew C, Clark AM (1994) Induction of two alternatively spliced Evi-1 proto-oncogene transcripts by cAMP in kidney cells. Oncogene 9:939\u2013942", "journal-title": "Oncogene"}, {"key": "21_CR43", "doi-asserted-by": "publisher", "first-page": "6454", "DOI": "10.1073/pnas.90.14.6454", "volume": "90", "author": "B Kreider", "year": "1993", "unstructured": "Kreider B, Orkin S, Ihle J (1993) Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid transforming gene. Proc Natl Acad Sci, USA 90:6454\u20136458", "journal-title": "Proc Natl Acad Sci, USA"}, {"key": "21_CR44", "first-page": "1243", "volume": "84", "author": "M Russell", "year": "1994", "unstructured": "Russell M, List A, Greenberg P, Woodward S, Glinsmann B, Parganas E, Ihle J, Taetle R (1994) Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. Blood 84:1243\u20131248", "journal-title": "Blood"}, {"key": "21_CR45", "doi-asserted-by": "crossref", "first-page": "2665", "DOI": "10.1128/MCB.11.5.2665", "volume": "11", "author": "AS Perkins", "year": "1991", "unstructured": "Perkins AS, Fishel R, Jenkins NA, Copeland NG (1991) Evi-l, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein. Mol Cell Biol 11:2665\u20132674", "journal-title": "Mol Cell Biol"}, {"key": "21_CR46", "first-page": "1575", "volume": "9", "author": "T Funabiki", "year": "1994", "unstructured": "Funabiki T, Kreider BL, Ihle JN (1994) The carboxyl domain of zinc fingers of the Evi-l myeloid transforming gene binds a consensus sequence GAAGATGAG. Oncogene 9:1575\u20131581", "journal-title": "Oncogene"}, {"key": "21_CR47", "doi-asserted-by": "publisher", "first-page": "1701", "DOI": "10.1126/science.8378770", "volume": "261", "author": "N Pavletich", "year": "1993", "unstructured": "Pavletich N, Pabo C (1993) Crystal structure of a five-finger GLI-DNA complex: new perspectives on zinc fingers. Science 261:1701\u20131707", "journal-title": "Science"}, {"key": "21_CR48", "doi-asserted-by": "publisher", "first-page": "809", "DOI": "10.1126/science.2028256", "volume": "252", "author": "N Pavletich", "year": "1991", "unstructured": "Pavletich N, Pabo C (1991) Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A,. Science 252:809\u2013817", "journal-title": "Science"}, {"key": "21_CR49", "doi-asserted-by": "publisher", "first-page": "1367", "DOI": "10.1126/science.1896847", "volume": "253", "author": "R Klevit", "year": "1991", "unstructured": "Klevit R (1991) Recognition of DNA by Cys2, His2 zinc fingers. Science 253:1367", "journal-title": "Science"}, {"key": "21_CR50", "doi-asserted-by": "publisher", "first-page": "3365", "DOI": "10.1021/bi00228a003", "volume": "30", "author": "R Xu", "year": "1991", "unstructured": "Xu R, Horvath S, Klevit R (1991) ADRla, a zinc finger peptide, exists in two folded conformations. Biochemistry 30:3365\u20133371", "journal-title": "Biochemistry"}, {"key": "21_CR51", "doi-asserted-by": "publisher", "first-page": "3371", "DOI": "10.1021/bi00228a004", "volume": "30", "author": "M Kochoyan", "year": "1991", "unstructured": "Kochoyan M, Havel TF, Nguyen DT, Dahl CE, Keutmann HT, Weiss MA (1991) Alternating zinc fingers in the human male associated protein ZFY: 2D NMR structure of an even finger and implications for \u201cjumping-linker\u201d DNA recognition. Biochemistry 30:3371\u20133386", "journal-title": "Biochemistry"}, {"key": "21_CR52", "doi-asserted-by": "publisher", "first-page": "5976", "DOI": "10.1073/pnas.85.16.5976", "volume": "85", "author": "T Evans", "year": "1988", "unstructured": "Evans T, Reitman M, Felsenfeld G (1988) An erythroid-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes. Proc. Natl. Acad. Sci. USA 85:5976\u20135980", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "21_CR53", "doi-asserted-by": "publisher", "first-page": "1089", "DOI": "10.1101/gad.2.9.1089", "volume": "2", "author": "L Wall", "year": "1988", "unstructured": "Wall L, deBoer E, Grosveld F (1988) The human \u03b2-globin gene 3\u2019 enhancer contains multiple binding sites for an erythroid-specific protein. Genes and Dev 2:1089\u20131100", "journal-title": "Genes and Dev"}, {"key": "21_CR54", "doi-asserted-by": "publisher", "first-page": "6548", "DOI": "10.1073/pnas.86.17.6548", "volume": "86", "author": "V Mignotte", "year": "1989", "unstructured": "Mignotte V, Eleouet F, Raich N, Romeo P (1989) Cis- and trans-acting elements involved in the regulation of the erythroid promoter of the human porphobilinogen deaminase gene. Proc Natl Acad Sci, USA 86:6548\u20136551", "journal-title": "Proc Natl Acad Sci, USA"}, {"key": "21_CR55", "doi-asserted-by": "publisher", "first-page": "6267", "DOI": "10.1073/pnas.85.17.6267", "volume": "85", "author": "M Reitman", "year": "1988", "unstructured": "Reitman M, Felsenfeld G (1988) Mutational analysis of the chicken beta-globin enhancer reveals two positive-acting domains. Proc Natl Acad Sci USA 85:6267\u20136271", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "21_CR56", "doi-asserted-by": "publisher", "first-page": "73", "DOI": "10.1093/nar/17.1.73", "volume": "17", "author": "M Plumb", "year": "1989", "unstructured": "Plumb M, Frampton J, Wainwright H, Walker M, Macleod K, Goodwin G, Harrison P (1989) GATAAG: a c/s-control region binding an erythroid-specific nuclear factor with a role in globin and non-globin gene expression. Nucleic Acids Research 17:73\u201393", "journal-title": "Nucleic Acids Research"}, {"key": "21_CR57", "doi-asserted-by": "publisher", "first-page": "435", "DOI": "10.1038/338435a0", "volume": "338", "author": "D Martin", "year": "1989", "unstructured": "Martin D, Tsai S, Orkin S (1989) Increased gamma-globin expression in a nondeletion HPFH mediated by an erythroid-specific DNA-binding factor. Nature 338:435\u2013438", "journal-title": "Nature"}, {"key": "21_CR58", "doi-asserted-by": "publisher", "first-page": "313", "DOI": "10.1016/0092-8674(88)90194-8", "volume": "54", "author": "C Glass", "year": "1988", "unstructured": "Glass C, Holloway J, Devary O, Rosenfeld M (1988) The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements. Cell 54:313\u2013323", "journal-title": "Cell"}, {"key": "21_CR59", "doi-asserted-by": "publisher", "first-page": "683", "DOI": "10.1038/335683a0", "volume": "335", "author": "M Ptashne", "year": "1988", "unstructured": "Ptashne M (1988) How eukaryotic transcriptional activators work. Nature 335:683\u2013689", "journal-title": "Nature"}, {"key": "21_CR60", "doi-asserted-by": "publisher", "first-page": "3274", "DOI": "10.1073/pnas.87.9.3274", "volume": "87", "author": "L Sompayrac", "year": "1990", "unstructured": "Sompayrac L, Danna K (1990) Method to identify genomic targets of DNA binding proteins. Proc. Natl. Acad. Sci. USA 87:3274\u20133278", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "21_CR61", "doi-asserted-by": "publisher", "first-page": "857", "DOI": "10.1073/pnas.77.2.857", "volume": "77", "author": "K McEntee", "year": "1980", "unstructured": "McEntee K, Weinstock G, Lehman I (1980) recA protein catalyzed assimilation. Stimulation by Escherichia coli single-stranded DNA-binding protein. Proc. Natl. Acad. Sci. USA 77:857\u2013861", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "21_CR62", "doi-asserted-by": "publisher", "first-page": "257", "DOI": "10.1038/349257a0", "volume": "349", "author": "L Pevny", "year": "1991", "unstructured": "Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF, D\u2019Agati V, Orkin S, Costantini F (1991) Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349:257\u2013260", "journal-title": "Nature"}, {"key": "21_CR63", "first-page": "24020", "volume": "269", "author": "T Tanaka", "year": "1994", "unstructured": "Tanaka T, Nishida J, Mitani K, Ogawa S, Yazaki Y, Hirai H (1994) Evi-l raises AP-1 activity and stimulates c-fos promoter transactivation with dependence on the second zinc finger domain. J Biol Chem 269:24020\u201324026", "journal-title": "J Biol Chem"}], "container-title": ["Molecular Aspects of Myeloid Stem Cell Development", "Current Topics in Microbiology and Immunology"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-3-642-85232-9_21", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 4]], "date-time": "2019-11-04T20:34:01Z", "timestamp": 1572899641000}, "score": 34.528065, "issued": {"date-parts": [[1996]]}, "ISBN": ["9783642852343", "9783642852329"], "references-count": 63, "URL": "http://dx.doi.org/10.1007/978-3-642-85232-9_21", "relation": {"cites": []}, "ISSN": ["0070-217X"], "issn-type": [{"value": "0070-217X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T12:33:54Z", "timestamp": 1574512434631}, "reference-count": 55, "publisher": "Wiley", "issue": "3", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1571, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011, 8]]}, "DOI": "10.1111/j.1365-2141.2011.08737.x", "type": "journal-article", "created": {"date-parts": [[2011, 5, 14]], "date-time": "2011-05-14T07:12:43Z", "timestamp": 1305357163000}, "page": "337-348", "source": "Crossref", "is-referenced-by-count": 13, "title": ["EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells"], "prefix": "10.1111", "volume": "154", "author": [{"given": "An", "family": "De Weer", "sequence": "first", "affiliation": []}, {"given": "Joni", "family": "Van der Meulen", "sequence": "additional", "affiliation": []}, {"given": "Pieter", "family": "Rondou", "sequence": "additional", "affiliation": []}, {"given": "Tom", "family": "Taghon", "sequence": "additional", "affiliation": []}, {"given": "Torsten A.", "family": "Konrad", "sequence": "additional", "affiliation": []}, {"given": "Katleen", "family": "De Preter", "sequence": "additional", "affiliation": []}, {"given": "Pieter", "family": "Mestdagh", "sequence": "additional", "affiliation": []}, {"given": "Tom", "family": "Van Maerken", "sequence": "additional", "affiliation": []}, {"given": "Nadine", "family": "Van Roy", "sequence": "additional", "affiliation": []}, {"given": "Marta", "family": "Jeison", "sequence": "additional", "affiliation": []}, {"given": "Isaac", "family": "Yaniv", "sequence": "additional", "affiliation": []}, {"given": "Barbara", "family": "Cauwelier", "sequence": "additional", "affiliation": []}, {"given": "Lucien", "family": "Noens", "sequence": "additional", "affiliation": []}, {"given": "H\u00e9l\u00e8ne-Antoine", "family": "Poirel", "sequence": "additional", "affiliation": []}, {"given": "Peter", "family": "Vandenberghe", "sequence": "additional", "affiliation": []}, {"given": "Fr\u00e9d\u00e9ric", "family": "Lambert", "sequence": "additional", "affiliation": []}, {"given": "Anne", "family": "De Paepe", "sequence": "additional", "affiliation": []}, {"given": "Maria Garc\u00eda", "family": "S\u00e1nchez", "sequence": "additional", "affiliation": []}, {"given": "Maria", "family": "Odero", "sequence": "additional", "affiliation": []}, {"given": "Bruno", "family": "Verhasselt", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Philipp\u00e9", "sequence": "additional", "affiliation": []}, {"given": "Joke", "family": "Vandesompele", "sequence": "additional", "affiliation": []}, {"given": "Rotraud", "family": "Wieser", "sequence": "additional", "affiliation": []}, {"given": "Nicole", "family": "Dastugue", "sequence": "additional", "affiliation": []}, {"given": "Pieter", "family": "Van Vlierberghe", "sequence": "additional", "affiliation": []}, {"given": "Bruce", "family": "Poppe", "sequence": "additional", "affiliation": []}, {"given": "Frank", "family": "Speleman", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2011, 5, 14]]}, "reference": [{"key": "10.1111/j.1365-2141.2011.08737.x-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1111/j.1349-7006.1996.tb00216.x", "article-title": "Establishment of an undifferentiated leukemia cell line (Kasumi-3) with t(3;7)(q27;q22) and activation of the EVI1 gene", "volume": "87", "author": "Asou", "year": "1996", "journal-title": "Japanese journal of cancer research"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "837", "DOI": "10.1182/blood-2002-05-1459", "article-title": "High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients", "volume": "101", "author": "Barjesteh van Waalwijk van Doorn-Khosrovani", "year": "2003", "journal-title": "Blood"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "7159", "DOI": "10.1158/0008-5472.CAN-05-1664", "article-title": "Suppression of p53 by Notch in lymphomagenesis: implications for initiation and regression", "volume": "65", "author": "Beverly", "year": "2005", "journal-title": "Cancer Research"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "e7850", "DOI": "10.1371/journal.pone.0007850", "article-title": "Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival", "volume": "4", "author": "Bray", "year": "2009", "journal-title": "PLoS ONE"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1016/j.febslet.2004.07.055", "article-title": "Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments", "volume": "573", "author": "Breitling", "year": "2004", "journal-title": "FEBS Letters"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "206", "DOI": "10.1016/S1079-9796(03)00159-1", "article-title": "The role of EVI1 in normal and leukemic cells", "volume": "31", "author": "Buonamici", "year": "2003", "journal-title": "Blood cells, molecules & diseases"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1038/ng.2007.30", "article-title": "Widespread microRNA repression by Myc contributes to tumorigenesis", "volume": "40", "author": "Chang", "year": "2008", "journal-title": "Nature Genetics"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "1903", "DOI": "10.3324/haematol.13192", "article-title": "EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22", "volume": "93", "author": "De Weer", "year": "2008", "journal-title": "Haematologica"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "2643", "DOI": "10.4161/cc.7.17.6597", "article-title": "Mechanisms of microRNA deregulation in human cancer", "volume": "7", "author": "Deng", "year": "2008", "journal-title": "Cell Cycle"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "9783", "DOI": "10.1073/pnas.1004297107", "article-title": "Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome", "volume": "107", "author": "Dickstein", "year": "2010", "journal-title": "Proceedings of the National Academy of Sciences of the United States of America"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB11|cit11", "first-page": "493", "article-title": "Is the cancer stem cell population \u201ca player\u201d in multi-drug resistance?", "volume": "65", "author": "Drewa", "year": "2008", "journal-title": "Acta Poloniae Pharmaceutica"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB12|cit12", "first-page": "47", "article-title": "Affordable image analysis using NIH Image/ImageJ", "volume": "41", "author": "Girish", "year": "2004", "journal-title": "Indian Journal of Cancer"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "1292", "DOI": "10.1038/sj.bjc.6605874", "article-title": "EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2", "volume": "103", "author": "Gomez-Benito", "year": "2010", "journal-title": "British Journal of Cancer"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1016/j.stem.2008.06.002", "article-title": "Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells", "volume": "3", "author": "Goyama", "year": "2008", "journal-title": "Cell Stem Cell"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "288", "DOI": "10.1002/gcc.20532", "article-title": "Expression and prognostic significance of different mRNA 5\u2032-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration", "volume": "47", "author": "Haas", "year": "2008", "journal-title": "Genes Chromosomes Cancer"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "R19", "DOI": "10.1186/gb-2007-8-2-r19", "article-title": "qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data", "volume": "8", "author": "Hellemans", "year": "2007", "journal-title": "Genome Biology"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "23473", "DOI": "10.1074/jbc.M800406200", "article-title": "MicroRNA expression and regulation in mouse uterus during embryo implantation", "volume": "283", "author": "Hu", "year": "2008", "journal-title": "Journal of Chemical Biology"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "669", "DOI": "10.1242/dev.02769", "article-title": "C. elegans EVI1 proto-oncogene, EGL-43, is necessary for Notch-mediated cell fate specification and regulates cell invasion", "volume": "134", "author": "Hwang", "year": "2007", "journal-title": "Development"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "813", "DOI": "10.1189/jlb.0109042", "article-title": "Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes", "volume": "86", "author": "Konrad", "year": "2009", "journal-title": "Journal of Leukocyte Biology"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB20|cit20", "first-page": "1080", "article-title": "NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)", "volume": "77", "author": "Lanotte", "year": "1991", "journal-title": "Blood"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "4329", "DOI": "10.1182/blood-2007-10-119230", "article-title": "High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated", "volume": "111", "author": "Lugthart", "year": "2008", "journal-title": "Blood"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "234", "DOI": "10.1182/blood-2010-04-281337", "article-title": "Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1", "volume": "117", "author": "Lugthart", "year": "2011", "journal-title": "Blood"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "2485", "DOI": "10.4161/cc.7.16.6453", "article-title": "microRNAs and cancer: an overview", "volume": "7", "author": "Medina", "year": "2008", "journal-title": "Cell Cycle"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "217", "DOI": "10.1016/j.cell.2008.04.001", "article-title": "miRiad roles for the miR-17-92 cluster in development and disease", "volume": "133", "author": "Mendell", "year": "2008", "journal-title": "Cell"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "e143", "DOI": "10.1093/nar/gkn725", "article-title": "High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA", "volume": "36", "author": "Mestdagh", "year": "2008", "journal-title": "Nucleic Acids Research"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "R64", "DOI": "10.1186/gb-2009-10-6-r64", "article-title": "A novel and universal method for microRNA RT-qPCR data normalization", "volume": "10", "author": "Mestdagh", "year": "2009", "journal-title": "Genome Biology"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1038/leu.2008.246", "article-title": "Targeting the leukemic stem cell: the Holy Grail of leukemia therapy", "volume": "23", "author": "Misaghian", "year": "2009", "journal-title": "Leukemia"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB28|cit28", "first-page": "93", "article-title": "Ki-67, cyclin D1, p53 and bcl-2 expression in advanced head and neck cancer", "volume": "17", "author": "Nagy", "year": "2003", "journal-title": "In Vivo"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "1714", "DOI": "10.1038/onc.2009.19", "article-title": "miR-449a targets HDAC-1 and induces growth arrest in prostate cancer", "volume": "28", "author": "Noonan", "year": "2009", "journal-title": "Oncogene"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.18632/oncotarget.167", "article-title": "miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells", "volume": "1", "author": "Noonan", "year": "2010", "journal-title": "Oncotarget"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "2022", "DOI": "10.1038/sj.leu.2400880", "article-title": "The EVI1 gene in myeloid leukemia", "volume": "11", "author": "Nucifora", "year": "1997", "journal-title": "Leukemia"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1210/me.2008-0387", "article-title": "MicroRNA-regulated pathways associated with endometriosis", "volume": "23", "author": "Ohlsson Teague", "year": "2009", "journal-title": "Molecular Endocrinology"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB33|cit33", "first-page": "1369", "article-title": "Characterization of a factor-dependent acute leukemia cell line with translocation (3;3)(q21;q26)", "volume": "76", "author": "Oval", "year": "1990", "journal-title": "Blood"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "5314", "DOI": "10.1158/1078-0432.CCR-07-4864", "article-title": "Oncogenic NOTCH1 control of MYC and PI3K: challenges and opportunities for anti-NOTCH1 therapy in T-cell acute lymphoblastic leukemias and lymphomas", "volume": "14", "author": "Palomero", "year": "2008", "journal-title": "Clinical Cancer Research"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1002/gcc.20295", "article-title": "EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements", "volume": "45", "author": "Poppe", "year": "2006", "journal-title": "Genes, chromosomes & cancer"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "493", "DOI": "10.1261/rna.1295509", "article-title": "Impact of normalization on miRNA microarray expression profiling", "volume": "15", "author": "Pradervand", "year": "2009", "journal-title": "RNA"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "3697", "DOI": "10.1021/bi702524v", "article-title": "Regulation of the calreticulin gene by GATA6 and Evi-1 transcription factors", "volume": "47", "author": "Qiu", "year": "2008", "journal-title": "Biochemistry"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "4677", "DOI": "10.1200/JCO.2005.05.5194", "article-title": "MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior", "volume": "24", "author": "Roldo", "year": "2006", "journal-title": "Journal of Clinical Oncology"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "856", "DOI": "10.1182/blood-2008-02-139725", "article-title": "Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells", "volume": "113", "author": "Rosati", "year": "2009", "journal-title": "Blood"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "699", "DOI": "10.1002/ijc.23153", "article-title": "MYCN regulates oncogenic MicroRNAs in neuroblastoma", "volume": "122", "author": "Schulte", "year": "2008", "journal-title": "International Journal of Cancer"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "4300", "DOI": "10.1182/blood-2008-11-187708", "article-title": "Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism", "volume": "113", "author": "Secchiero", "year": "2009", "journal-title": "Blood"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "4364", "DOI": "10.1038/onc.2009.288", "article-title": "Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells", "volume": "28", "author": "Shimabe", "year": "2009", "journal-title": "Oncogene"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "2761", "DOI": "10.1016/j.febslet.2008.06.056", "article-title": "A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a", "volume": "582", "author": "Spensberger", "year": "2008", "journal-title": "FEBS Letters"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB44|cit44", "doi-asserted-by": "crossref", "first-page": "1755", "DOI": "10.1038/sj.leu.2402682", "article-title": "The human promyelocytic leukemia zinc finger gene is regulated by the Evi-1 oncoprotein and a novel guanine-rich site binding protein", "volume": "16", "author": "Takahashi", "year": "2002", "journal-title": "Leukemia"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB45|cit45", "doi-asserted-by": "crossref", "first-page": "1241", "DOI": "10.1038/leu.2008.53", "article-title": "AML1-Evi-1 specifically transforms hematopoietic stem cells through fusion of the entire Evi-1 sequence to AML1", "volume": "22", "author": "Takeshita", "year": "2008", "journal-title": "Leukemia"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB46|cit46", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1080/10408360500295626", "article-title": "BCL2 family of apoptosis-related genes: functions and clinical implications in cancer", "volume": "43", "author": "Thomadaki", "year": "2006", "journal-title": "Critical Reviews in Clinical Laboratory Sciences"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB47|cit47", "doi-asserted-by": "crossref", "first-page": "e3726", "DOI": "10.1371/journal.pone.0003726", "article-title": "MicroRNA expression patterns and function in endodermal differentiation of human embryonic stem cells", "volume": "3", "author": "Tzur", "year": "2008", "journal-title": "PLoS ONE"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB48|cit48", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1186/gb-2002-3-7-research0034", "article-title": "Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes", "volume": "3", "author": "Vandesompele", "year": "2002", "journal-title": "Genome Biology"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB49|cit49", "doi-asserted-by": "crossref", "first-page": "E167", "DOI": "10.1073/pnas.1011540107", "article-title": "Silencing of hsa-miR-124 by EVI1 in cell lines and patients with acute myeloid leukemia", "volume": "107", "author": "Vazquez", "year": "2010", "journal-title": "Proceedings of the National Academy of Sciences of the United States of America"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB50|cit50", "doi-asserted-by": "crossref", "first-page": "562", "DOI": "10.1093/humrep/den439", "article-title": "Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation", "volume": "24", "author": "Wang", "year": "2009", "journal-title": "Human Reproduction"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB51|cit51", "doi-asserted-by": "crossref", "first-page": "2588", "DOI": "10.1158/1078-0432.CCR-07-0666", "article-title": "Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue", "volume": "14", "author": "Wong", "year": "2008", "journal-title": "Clinical Cancer Research"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB52|cit52", "first-page": "451", "article-title": "Establishment and characterization of a new human leukemia cell line derived from M4E0", "volume": "78", "author": "Yanagisawa", "year": "1991", "journal-title": "Blood"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB53|cit53", "doi-asserted-by": "crossref", "first-page": "2388", "DOI": "10.1101/gad.1819009", "article-title": "miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A", "volume": "23", "author": "Yang", "year": "2009", "journal-title": "Genes and Development"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB54|cit54", "doi-asserted-by": "crossref", "first-page": "30712", "DOI": "10.1074/jbc.M504293200", "article-title": "Identification of binding sites of EVI1 in mammalian cells", "volume": "280", "author": "Yatsula", "year": "2005", "journal-title": "Journal of Chemical Biology"}, {"key": "10.1111/j.1365-2141.2011.08737.x-BIB55|cit55", "doi-asserted-by": "crossref", "first-page": "1976", "DOI": "10.1038/sj.emboj.7600679", "article-title": "Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression", "volume": "24", "author": "Yuasa", "year": "2005", "journal-title": "EMBO Journal"}], "container-title": ["British Journal of Haematology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2141.2011.08737.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 20]], "date-time": "2017-06-20T00:12:05Z", "timestamp": 1497917525000}, "score": 33.732803, "subtitle": ["The Role of MIR449A in EVI1 Pathogenesis"], "issued": {"date-parts": [[2011, 5, 14]]}, "references-count": 55, "journal-issue": {"published-print": {"date-parts": [[2011, 8]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1111/j.1365-2141.2011.08737.x", "relation": {"cites": []}, "ISSN": ["0007-1048"], "issn-type": [{"value": "0007-1048", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T16:22:54Z", "timestamp": 1574698974111}, "reference-count": 74, "publisher": "Future Medicine Ltd", "issue": "11", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Future Oncology"], "published-print": {"date-parts": [[2015, 6]]}, "DOI": "10.2217/fon.15.64", "type": "journal-article", "created": {"date-parts": [[2015, 6, 4]], "date-time": "2015-06-04T15:57:29Z", "timestamp": 1433433449000}, "page": "1675-1686", "source": "Crossref", "is-referenced-by-count": 10, "title": ["3q26/EVI1 rearrangements in myeloid hemopathies: a cytogenetic review"], "prefix": "10.2217", "volume": "11", "author": [{"given": "Marc", "family": "De Braekeleer", "sequence": "first", "affiliation": []}, {"given": "Marie-Jos\u00e9e", "family": "Le Bris", "sequence": "additional", "affiliation": []}, {"given": "Etienne", "family": "De Braekeleer", "sequence": "additional", "affiliation": []}, {"given": "Audrey", "family": "Basinko", "sequence": "additional", "affiliation": []}, {"given": "Fr\u00e9d\u00e9ric", "family": "Morel", "sequence": "additional", "affiliation": []}, {"given": "Nathalie", "family": "Douet-Guilbert", "sequence": "additional", "affiliation": []}], "member": "1057", "reference": [{"key": "B1", "DOI": "10.1111/j.1349-7006.2012.02303.x", "doi-asserted-by": "publisher"}, {"key": "B2", "DOI": "10.1016/j.bcmd.2014.01.002", "doi-asserted-by": "publisher"}, {"key": "B3", "DOI": "10.1016/S1079-9796(03)00159-1", "doi-asserted-by": "publisher"}, {"key": "B4", "DOI": "10.1016/j.gene.2007.04.012", "doi-asserted-by": "publisher"}, {"key": "B5", "DOI": "10.1371/journal.pone.0067134", "doi-asserted-by": "publisher"}, {"key": "B6", "DOI": "10.1073/pnas.91.9.4004", "doi-asserted-by": "publisher"}, {"key": "B7", "DOI": "10.1038/sj.leu.2400880", "doi-asserted-by": "publisher"}, {"key": "B8", "DOI": "10.1074/jbc.M504293200", "doi-asserted-by": "publisher"}, {"key": "B9", "DOI": "10.1038/sj.emboj.7600679", "doi-asserted-by": "publisher"}, {"key": "B10", "DOI": "10.1038/onc.2009.288", "doi-asserted-by": "publisher"}, {"key": "B11", "DOI": "10.1074/jbc.M410836200", "doi-asserted-by": "publisher"}, {"key": "B12", "DOI": "10.1038/27945", "doi-asserted-by": "publisher"}, {"key": "B13", "DOI": "10.1182/blood.V97.9.2815", "doi-asserted-by": "publisher"}, {"key": "B14", "DOI": "10.18632/oncotarget.304", "doi-asserted-by": "publisher"}, {"key": "B15", "DOI": "10.1046/j.1365-2141.2001.02987.x", "doi-asserted-by": "publisher"}, {"key": "B16", "DOI": "10.1074/jbc.M106733200", "doi-asserted-by": "publisher"}, {"key": "B17", "DOI": "10.1002/jcb.21869", "doi-asserted-by": "publisher"}, {"key": "B18", "DOI": "10.1016/j.febslet.2008.06.056", "doi-asserted-by": "publisher"}, {"key": "B19", "DOI": "10.1038/leu.2009.202", "doi-asserted-by": "publisher"}, {"key": "B20", "DOI": "10.1371/journal.pone.0020793", "doi-asserted-by": "publisher"}, {"key": "B21", "author": "Russell M", "volume": "84", "first-page": "1243", "year": "1994", "journal-title": "Blood"}, {"key": "B22", "DOI": "10.1182/blood-2002-05-1459", "doi-asserted-by": "publisher"}, {"key": "B23", "DOI": "10.1046/j.1365-2141.2001.02569.x", "doi-asserted-by": "publisher"}, {"key": "B24", "DOI": "10.1200/JCO.2009.26.0646", "doi-asserted-by": "publisher"}, {"key": "B25", "DOI": "10.1038/leu.2010.47", "doi-asserted-by": "publisher"}, {"key": "B26", "DOI": "10.1371/journal.pone.0008676", "doi-asserted-by": "publisher"}, {"key": "B27", "DOI": "10.1182/blood-2009-03-209262", "doi-asserted-by": "publisher"}, {"key": "B28", "author": "Bitter MA", "volume": "66", "first-page": "1362", "year": "1985", "journal-title": "Blood"}, {"key": "B29", "author": "Fonatsch C", "volume": "8", "first-page": "1318", "year": "1994", "journal-title": "Leukemia"}, {"key": "B30", "DOI": "10.3109/10428199509054422", "doi-asserted-by": "publisher"}, {"key": "B31", "DOI": "10.1080/10428190210196", "doi-asserted-by": "publisher"}, {"key": "B32", "DOI": "10.1200/JCO.2010.29.2771", "doi-asserted-by": "publisher"}, {"key": "B33", "DOI": "10.1038/sj.thj.6200143", "doi-asserted-by": "publisher"}, {"key": "B34", "DOI": "10.1111/j.1365-2141.2007.06505.x", "doi-asserted-by": "publisher"}, {"key": "B35", "author": "De Braekeleer E", "volume": "31", "first-page": "3441", "year": "2011", "journal-title": "Anticancer Res."}, {"key": "B36", "author": "De Braekeleer E", "volume": "33", "first-page": "639", "year": "2013", "journal-title": "Anticancer Res."}, {"key": "B37", "DOI": "10.1016/j.cancergen.2011.06.002", "doi-asserted-by": "publisher"}, {"key": "B40", "DOI": "10.1038/nm.2088", "doi-asserted-by": "publisher"}, {"key": "B41", "DOI": "10.1182/blood-2008-05-159905", "doi-asserted-by": "publisher"}, {"key": "B42", "DOI": "10.1182/blood-2008-06-162263", "doi-asserted-by": "publisher"}, {"key": "B43", "DOI": "10.1182/blood-2014-07-591529", "doi-asserted-by": "publisher"}, {"key": "B44", "DOI": "10.1182/blood-2005-03-1115", "doi-asserted-by": "publisher"}, {"key": "B45", "DOI": "10.1016/S0165-4608(00)00245-4", "doi-asserted-by": "publisher"}, {"key": "B46", "DOI": "10.1007/s00277-010-0937-x", "doi-asserted-by": "publisher"}, {"key": "B47", "author": "Raynaud SD", "volume": "88", "first-page": "682", "year": "1996", "journal-title": "Blood"}, {"key": "B48", "DOI": "10.1002/gcc.20033", "doi-asserted-by": "publisher"}, {"key": "B49", "DOI": "10.1007/s00277-003-0778-y", "doi-asserted-by": "publisher"}, {"key": "B50", "DOI": "10.1002/gcc.20295", "doi-asserted-by": "publisher"}, {"key": "B51", "DOI": "10.1016/j.cancergencyto.2007.05.007", "doi-asserted-by": "publisher"}, {"key": "B52", "DOI": "10.1002/ajh.21746", "doi-asserted-by": "publisher"}, {"key": "B53", "DOI": "10.1016/j.cancergencyto.2006.05.007", "doi-asserted-by": "publisher"}, {"key": "B54", "DOI": "10.1038/sj.leu.2404906", "doi-asserted-by": "publisher"}, {"key": "B55", "DOI": "10.1002/gcc.21992", "doi-asserted-by": "publisher"}, {"key": "B56", "author": "Wieser R", "volume": "88", "first-page": "25", "year": "2003", "journal-title": "Haematologica"}, {"key": "B57", "DOI": "10.1002/gcc.20033", "doi-asserted-by": "publisher"}, {"key": "B58", "DOI": "10.1073/pnas.89.9.3937", "doi-asserted-by": "publisher"}, {"key": "B59", "author": "Levy ER", "volume": "83", "first-page": "1348", "year": "1994", "journal-title": "Blood"}, {"key": "B60", "author": "Suzukawa K", "volume": "84", "first-page": "2681", "year": "1994", "journal-title": "Blood"}, {"key": "B61", "DOI": "10.1038/sj.leu.2403346", "doi-asserted-by": "publisher"}, {"key": "B62", "DOI": "10.1038/sj.leu.2404020", "doi-asserted-by": "publisher"}, {"key": "B63", "DOI": "10.1016/j.cancergencyto.2007.09.023", "doi-asserted-by": "publisher"}, {"key": "B64", "DOI": "10.1007/s00277-013-1750-0", "doi-asserted-by": "publisher"}, {"key": "B65", "DOI": "10.1016/j.bcmd.2014.11.015", "doi-asserted-by": "publisher"}, {"key": "B66", "DOI": "10.3324/haematol.13192", "doi-asserted-by": "publisher"}, {"key": "B67", "author": "Peeters P", "volume": "57", "first-page": "564", "year": "1997", "journal-title": "Cancer Res."}, {"key": "B68", "DOI": "10.1073/pnas.0904715106", "doi-asserted-by": "publisher"}, {"key": "B69", "DOI": "10.1038/nature07672", "doi-asserted-by": "publisher"}, {"key": "B70", "DOI": "10.1126/science.1192002", "doi-asserted-by": "publisher"}, {"key": "B71", "DOI": "10.1038/nature09819", "doi-asserted-by": "publisher"}, {"key": "B72", "DOI": "10.1038/nature08975", "doi-asserted-by": "publisher"}, {"key": "B73", "DOI": "10.1093/hmg/ddq353", "doi-asserted-by": "publisher"}, {"key": "B74", "DOI": "10.1155/2011/329471", "doi-asserted-by": "publisher"}, {"key": "B75", "DOI": "10.1016/j.cell.2014.02.019", "doi-asserted-by": "publisher"}, {"key": "B76", "DOI": "10.1182/blood-2014-07-591461", "doi-asserted-by": "publisher"}], "container-title": ["Future Oncology"], "language": "en", "link": [{"URL": "https://www.futuremedicine.com/doi/pdf/10.2217/fon.15.64", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T10:02:55Z", "timestamp": 1574244175000}, "score": 33.05496, "issued": {"date-parts": [[2015, 6]]}, "references-count": 74, "journal-issue": {"published-print": {"date-parts": [[2015, 6]]}, "issue": "11"}, "alternative-id": ["10.2217/fon.15.64"], "URL": "http://dx.doi.org/10.2217/fon.15.64", "relation": {"cites": []}, "ISSN": ["1479-6694", "1744-8301"], "issn-type": [{"value": "1479-6694", "type": "print"}, {"value": "1744-8301", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T09:07:40Z", "timestamp": 1574240860465}, "reference-count": 5, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 11, 1]], "date-time": "2006-11-01T00:00:00Z", "timestamp": 1162339200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Genetics and Cytogenetics"], "published-print": {"date-parts": [[2006, 11]]}, "DOI": "10.1016/j.cancergencyto.2006.07.004", "type": "journal-article", "created": {"date-parts": [[2006, 10, 30]], "date-time": "2006-10-30T16:51:16Z", "timestamp": 1162227076000}, "page": "79-80", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Screening for EVI1: ectopic expression absent in T-cell acute lymphoblastic leukemia patients and cell lines"], "prefix": "10.1016", "volume": "171", "author": [{"given": "A.", "family": "De Weer", "sequence": "first", "affiliation": []}, {"given": "B.", "family": "Poppe", "sequence": "additional", "affiliation": []}, {"given": "B.", "family": "Cauwelier", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Van Roy", "sequence": "additional", "affiliation": []}, {"given": "N.", "family": "Dastugue", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Hagemeijer", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "De Paepe", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Speleman", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cancer Genetics and Cytogenetics"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0165460806004651?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0165460806004651?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 11]], "date-time": "2019-01-11T21:21:39Z", "timestamp": 1547241699000}, "score": 31.856186, "issued": {"date-parts": [[2006, 11]]}, "references-count": 5, "journal-issue": {"published-print": {"date-parts": [[2006, 11]]}, "issue": "1"}, "alternative-id": ["S0165460806004651"], "URL": "http://dx.doi.org/10.1016/j.cancergencyto.2006.07.004", "ISSN": ["0165-4608"], "issn-type": [{"value": "0165-4608", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:28:37Z", "timestamp": 1575530917505}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "4", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[1994, 8, 15]]}, "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>The EVI1 gene encodes a zinc-finger, DNA-binding protein originally described as the transforming gene associated with a common ecotropic viral insertion site in myeloid leukemias. Previous studies demonstrated EVI1 expression in human leukemias in cases with 3q26 translocations, but not in normal blood or bone marrow. These studies also suggested an association between EVI1 expression and chromosome 7 deletion (del). Because of this association, we examined expression of EVI1 using RNA polymerase chain reaction (PCR) in patients with myelodysplastic syndromes (MDS) and acute leukemia with and without 3q26 translocations. EVI1 RNA was expressed in 29% of 34 (95% confidence interval, 20% to 50%) patients with the MDS subtypes refractory anemia (RA), refractory anemia with excess blasts (RAEB), or refractory anemia with excess blasts in transformation (RAEB-T). The vast majority of these cases occurred in patients with RAEB and RAEB-T. EVI1 expression was not detected in patients with chronic myelomonocytic leukemia (CMML), normal bone marrow or cord blood, or a variety of other hematologic malignancies. EVI1 RNA was detected in three of 18 patients with acute myelogenous leukemia (AML) and in two of four patients with acute promyelocytic leukemia (APL). Karyotypes showed that only one AML patient had karyotype 3q26 abnormalities, indicating that EVI1 expression is associated with cases that do not have structural abnormalities involving chromosome 3q26. These studies document for the first time the abnormal expression of EVI1 RNA by patients with MDS, and suggest an important role for EVI1 in the pathogenesis or progression of some myeloid malignancies.</jats:p>", "DOI": "10.1182/blood.v84.4.1243.1243", "type": "journal-article", "created": {"date-parts": [[2019, 10, 14]], "date-time": "2019-10-14T04:17:20Z", "timestamp": 1571026640000}, "page": "1243-1248", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations"], "prefix": "10.1182", "volume": "84", "author": [{"given": "M", "family": "Russell", "sequence": "first", "affiliation": [{"name": "Department of Medicine, University of Arizona, Tucson."}]}, {"given": "A", "family": "List", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Arizona, Tucson."}]}, {"given": "P", "family": "Greenberg", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Arizona, Tucson."}]}, {"given": "S", "family": "Woodward", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Arizona, Tucson."}]}, {"given": "B", "family": "Glinsmann", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Arizona, Tucson."}]}, {"given": "E", "family": "Parganas", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Arizona, Tucson."}]}, {"given": "J", "family": "Ihle", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Arizona, Tucson."}]}, {"given": "R", "family": "Taetle", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Arizona, Tucson."}]}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "http://ashpublications.org/blood/article-pdf/84/4/1243/618935/1243.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/blood/article-pdf/84/4/1243/618935/1243.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T10:50:08Z", "timestamp": 1574247008000}, "score": 31.512928, "issued": {"date-parts": [[1994, 8, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1994, 8, 15]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1182/blood.v84.4.1243.1243", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:19:41Z", "timestamp": 1575530381135}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "4", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[1994, 8, 15]]}, "abstract": "<jats:p>The EVI1 gene encodes a zinc-finger, DNA-binding protein originally described as the transforming gene associated with a common ecotropic viral insertion site in myeloid leukemias. Previous studies demonstrated EVI1 expression in human leukemias in cases with 3q26 translocations, but not in normal blood or bone marrow. These studies also suggested an association between EVI1 expression and chromosome 7 deletion (del). Because of this association, we examined expression of EVI1 using RNA polymerase chain reaction (PCR) in patients with myelodysplastic syndromes (MDS) and acute leukemia with and without 3q26 translocations. EVI1 RNA was expressed in 29% of 34 (95% confidence interval, 20% to 50%) patients with the MDS subtypes refractory anemia (RA), refractory anemia with excess blasts (RAEB), or refractory anemia with excess blasts in transformation (RAEB-T). The vast majority of these cases occurred in patients with RAEB and RAEB-T. EVI1 expression was not detected in patients with chronic myelomonocytic leukemia (CMML), normal bone marrow or cord blood, or a variety of other hematologic malignancies. EVI1 RNA was detected in three of 18 patients with acute myelogenous leukemia (AML) and in two of four patients with acute promyelocytic leukemia (APL). Karyotypes showed that only one AML patient had karyotype 3q26 abnormalities, indicating that EVI1 expression is associated with cases that do not have structural abnormalities involving chromosome 3q26. These studies document for the first time the abnormal expression of EVI1 RNA by patients with MDS, and suggest an important role for EVI1 in the pathogenesis or progression of some myeloid malignancies.</jats:p>", "DOI": "10.1182/blood.v84.4.1243.bloodjournal8441243", "type": "journal-article", "created": {"date-parts": [[2019, 10, 13]], "date-time": "2019-10-13T08:53:41Z", "timestamp": 1570956821000}, "page": "1243-1248", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations"], "prefix": "10.1182", "volume": "84", "author": [{"given": "M", "family": "Russell", "sequence": "first", "affiliation": [{"name": "Department of Medicine, University of Arizona, Tucson."}]}, {"given": "A", "family": "List", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Arizona, Tucson."}]}, {"given": "P", "family": "Greenberg", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Arizona, Tucson."}]}, {"given": "S", "family": "Woodward", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Arizona, Tucson."}]}, {"given": "B", "family": "Glinsmann", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Arizona, Tucson."}]}, {"given": "E", "family": "Parganas", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Arizona, Tucson."}]}, {"given": "J", "family": "Ihle", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Arizona, Tucson."}]}, {"given": "R", "family": "Taetle", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Arizona, Tucson."}]}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "http://ashpublications.org/blood/article-pdf/84/4/1243/230967/1243.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/blood/article-pdf/84/4/1243/230967/1243.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T04:06:38Z", "timestamp": 1574222798000}, "score": 31.512928, "issued": {"date-parts": [[1994, 8, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1994, 8, 15]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1182/blood.v84.4.1243.bloodjournal8441243", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T06:45:50Z", "timestamp": 1574405150278}, "reference-count": 0, "publisher": "Public Library of Science (PLoS)", "issue": "1", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0/", "start": {"date-parts": [[2010, 1, 13]], "date-time": "2010-01-13T00:00:00Z", "timestamp": 1263340800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": ["www.plosone.org"], "crossmark-restriction": false}, "short-container-title": ["PLoS ONE"], "DOI": "10.1371/journal.pone.0008676", "type": "journal-article", "created": {"date-parts": [[2010, 1, 12]], "date-time": "2010-01-12T23:26:47Z", "timestamp": 1263338807000}, "page": "e8676", "update-policy": "http://dx.doi.org/10.1371/journal.pone.corrections_policy", "source": "Crossref", "is-referenced-by-count": 14, "title": ["Identification of Two Critically Deleted Regions within Chromosome Segment 7q35-q36 in EVI1 Deregulated Myeloid Leukemia Cell Lines"], "prefix": "10.1371", "volume": "5", "author": [{"given": "An", "family": "De Weer", "sequence": "first", "affiliation": []}, {"given": "Bruce", "family": "Poppe", "sequence": "additional", "affiliation": []}, {"given": "Sarah", "family": "Vergult", "sequence": "additional", "affiliation": []}, {"given": "Pieter", "family": "Van Vlierberghe", "sequence": "additional", "affiliation": []}, {"given": "Marjan", "family": "Petrick", "sequence": "additional", "affiliation": []}, {"given": "Robrecht", "family": "De Bock", "sequence": "additional", "affiliation": []}, {"given": "Yves", "family": "Benoit", "sequence": "additional", "affiliation": []}, {"given": "Lucien", "family": "Noens", "sequence": "additional", "affiliation": []}, {"given": "Anne", "family": "De Paepe", "sequence": "additional", "affiliation": []}, {"given": "Nadine", "family": "Van Roy", "sequence": "additional", "affiliation": []}, {"given": "Bj\u00f6rn", "family": "Menten", "sequence": "additional", "affiliation": []}, {"given": "Frank", "family": "Speleman", "sequence": "additional", "affiliation": []}], "member": "340", "published-online": {"date-parts": [[2010, 1, 13]]}, "container-title": ["PLoS ONE"], "language": "en", "deposited": {"date-parts": [[2018, 10, 22]], "date-time": "2018-10-22T16:10:55Z", "timestamp": 1540224655000}, "score": 31.342148, "editor": [{"given": "Anita", "family": "Brandstaetter", "sequence": "first", "affiliation": []}], "issued": {"date-parts": [[2010, 1, 13]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2010, 1, 13]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1371/journal.pone.0008676", "ISSN": ["1932-6203"], "issn-type": [{"value": "1932-6203", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T20:59:11Z", "timestamp": 1574110751308}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2004, 2, 1]], "date-time": "2004-02-01T00:00:00Z", "timestamp": 1075593600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Annals of Hematology"], "published-print": {"date-parts": [[2004, 2, 1]]}, "DOI": "10.1007/s00277-003-0778-y", "type": "journal-article", "created": {"date-parts": [[2004, 1, 24]], "date-time": "2004-01-24T03:00:19Z", "timestamp": 1074913219000}, "page": "78-83", "source": "Crossref", "is-referenced-by-count": 15, "title": ["A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1"], "prefix": "10.1007", "volume": "83", "author": [{"given": "C. T.", "family": "Storlazzi", "sequence": "first", "affiliation": []}, {"given": "L.", "family": "Anelli", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Albano", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Zagaria", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Ventura", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Rocchi", "sequence": "additional", "affiliation": []}, {"given": "I.", "family": "Panagopoulos", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Pannunzio", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Ottaviani", "sequence": "additional", "affiliation": []}, {"given": "V.", "family": "Liso", "sequence": "additional", "affiliation": []}, {"given": "G.", "family": "Specchia", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["Annals of Hematology"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00277-003-0778-y.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00277-003-0778-y/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00277-003-0778-y", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 28]], "date-time": "2019-05-28T09:44:44Z", "timestamp": 1559036684000}, "score": 30.771116, "issued": {"date-parts": [[2004, 2, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 2, 1]]}, "issue": "2"}, "alternative-id": ["WMQGY4T76DMKP8L5"], "URL": "http://dx.doi.org/10.1007/s00277-003-0778-y", "ISSN": ["0939-5555", "1432-0584"], "issn-type": [{"value": "0939-5555", "type": "print"}, {"value": "1432-0584", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T06:56:03Z", "timestamp": 1575528963931}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "21", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2014, 12, 6]]}, "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>Introduction: Acute myeloid leukemia (AML) with inv(3)(q21q26) or t(3;3)(q21;q26) [inv(3)/t(3;3)] is associated with aberrant expression of the stem cell regulator EVI1 and dismal prognosis. Recently, we and others (Gr\u00f6schel et al, Cell, 2014; Yamazaki et al, Cancer Cell, 2014) have shown, as a consequence of the inv(3)/t(3;3) rearrangements, that the proto-oncogene EVI1 is activated upon the structural repositioning of a distal GATA2 enhancer from 3q21 to EVI1, coinciding with loss of GATA2 expression from the rearranged allele. Notably, GATA2 deficiency has been shown to impair hematopoietic stem cell frequency and function (Lim et al, J. Clin. Invest., 2012) and Evi1 activation in inv(3) murine models is followed by leukemia onset after a long latency of 6 months (Yamazaki et al). We therefore hypothesize that additional cooperating genetic lesions, other than EVI1 activation and GATA2 deregulation, are required for full leukemic transformation. We sought to extend the molecular characterization of inv(3)/t(3;3) myeloid malignancies through next-generation sequencing.</jats:p>\n               <jats:p>Methods: We selected 32 AML (including cell lines MUTZ-3 and UCSD-AML1), 4 CML-BC (including cell lines HNT-34 and MOLM-1), and 5 myelodysplastic syndrome (MDS) cases with inv(3)/t(3;3) rearrangements and performed whole transcriptome sequencing (n=40) as well as whole exome sequencing (WES, n=10) on the Illumina HiSeq 2500. For WES germline control we used DNA from cultured CD3+ T-cells from diagnostic bone marrow specimens. Variants were examined when recurrently detected in more than two patients or previously associated with leukemogenesis or cancer pathogenesis. Gene expression profiles (GEP) were constructed for 24 cases for subsequent analyses.</jats:p>\n               <jats:p>Results: All examined variants, validated by Sanger sequencing, were assigned to mutational categories to discern patterns of mutations (Figure 1A). We observed that all 41 cases acquired at least one mutation belonging to the mutational categories reported as relevant for leukemia pathogenesis. Importantly, all AML and CML-BC patients, as well as 4 out of 5 MDS patients contained mutations in genes activating RAS/RTK signaling, amounting to 98% of all inv(3)/t(3;3) myeloid malignancies. An aggregate of 74% of all patients harbor mutually exclusive mutations in RAS-pathway associated genes; NRAS(27%), PTPN11(20%), KRAS(11%), and NF1(9%). Additionally, we found mutations in genes affecting signaling pathways involving RAS; FLT3(13%), BCR-ABL(11%), and KIT(2%) (Figure 1B). NPM1, CEBPA, and IDH1/2 mutations were absent in all cases. Furthermore, frequent mutations were found in transcription factor (32%), splice factor (29%), epigenetic modifier (29%), and tumor suppressor (10%) encoding genes (Figure 1A). GATA2 is the most commonly mutated transcription factor in inv(3)/t(3;3) myeloid malignancies (15%). As these mutations were found on the non-rearranged GATA2 allele, only mutant GATA2 is expressed due to GATA2 silencing mediated by the 3q21q26 rearrangement. Novel somatic truncating mutations and copy number loss were detected in the transcription factor FOXP1(10%). Additionally, we observed frequent mutations in the splice factor gene SF3B1(27%) in AML and MDS cases. Finally, the predominant monosomal karyotype within inv(3)/t(3;3) myeloid malignancies is contrasted by the low incidence of TP53 mutations (5%). No mutational pattern alluded to the high coincidence of monosomy 7 (68%), but inv(3)/t(3;3)/-7 cases were characterized by a strong down regulation of the transcription factor CUX1.</jats:p>\n               <jats:p>In an effort to discriminate MDS and AML with inv(3)/t(3;3) we performed cluster and principle component analyses, revealing no cluster formation. Additionally, differential expression analysis was unable to differentiate AML from MDS, indicating strong homogeneity based on GEPs.</jats:p>\n               <jats:p>Conclusion: Myeloid malignancies with inv(3)/t(3;3) harbor a common set of molecular alterations, i.e. EVI1 activation and GATA2 deregulation, conjugated by mutations activating signaling pathways. Mutational patterns and GEPs precluded the discrimination of MDS and AML with inv(3)/t(3;3), supporting the notion that these myeloid disorders should be categorized as AML irrespective of blast count. Exploiting signaling pathways therapeutically may prove a valuable adjunct to the scarce armamentarium of drugs effective in this malignancy.</jats:p>\n               <jats:p>Figure 1 Figure 1.</jats:p>\n               <jats:sec>\n                  <jats:title>Disclosures</jats:title>\n                  <jats:p>No relevant conflicts of interest to declare.</jats:p>\n               </jats:sec>", "DOI": "10.1182/blood.v124.21.701.701", "type": "journal-article", "created": {"date-parts": [[2019, 10, 11]], "date-time": "2019-10-11T10:26:05Z", "timestamp": 1570789565000}, "page": "701-701", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Defects in the RAS/RTK Signaling Pathways Predominate the Mutational Spectrum of EVI1/GATA2 Rearranged Myeloid Malignancies with Inv(3)/t(3;3)"], "prefix": "10.1182", "volume": "124", "author": [{"given": "Mathijs A.", "family": "Sanders", "sequence": "first", "affiliation": [{"name": "Erasmus University Medical Center, Erasmus MC Cancer Institute, Rotterdam, Netherlands"}]}, {"given": "Stefan", "family": "Gr\u00f6schel", "sequence": "additional", "affiliation": [{"name": "Erasmus University Medical Center, Rotterdam, Netherlands"}]}, {"given": "Remco M.", "family": "Hoogenboezem", "sequence": "additional", "affiliation": [{"name": "Erasmus University Medical Center, Rotterdam, Netherlands"}]}, {"given": "Annelieke", "family": "Zeilemaker", "sequence": "additional", "affiliation": [{"name": "Erasmus University Medical Center, Rotterdam, Netherlands"}]}, {"given": "Marije", "family": "Havermans", "sequence": "additional", "affiliation": [{"name": "Erasmus University Medical Center, Rotterdam, Netherlands"}]}, {"given": "Claudia", "family": "Erpelinck", "sequence": "additional", "affiliation": [{"name": "Erasmus University Medical Center, Rotterdam, Netherlands"}]}, {"given": "Eric M. J.", "family": "Bindels", "sequence": "additional", "affiliation": [{"name": "Erasmus University Medical Center, Rotterdam, Netherlands"}]}, {"given": "Berna", "family": "Beverloo", "sequence": "additional", "affiliation": [{"name": "Erasmus University Medical Center, Rotterdam, Netherlands"}]}, {"given": "Hartmut", "family": "D\u00f6hner", "sequence": "additional", "affiliation": [{"name": "University Hospital of Ulm, Ulm, Germany"}]}, {"given": "Bob", "family": "L\u00f6wenberg", "sequence": "additional", "affiliation": [{"name": "Erasmus University Medical Center, Rotterdam, Netherlands"}]}, {"given": "Konstanze", "family": "D\u00f6hner", "sequence": "additional", "affiliation": [{"name": "University Hospital of Ulm, Ulm, Germany"}]}, {"given": "Ruud", "family": "Delwel", "sequence": "additional", "affiliation": [{"name": "Erasmus University Medical Center, Rotterdam, Netherlands"}]}, {"given": "Peter J.M.", "family": "Valk", "sequence": "additional", "affiliation": [{"name": "Erasmus University Medical Center Cancer Institute, Rotterdam, Netherlands"}]}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "https://ashpublications.org/blood/article/124/21/701/102128/Defects-in-the-RASRTK-Signaling-Pathways", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "https://ashpublications.org/blood/article/124/21/701/102128/Defects-in-the-RASRTK-Signaling-Pathways", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T10:11:29Z", "timestamp": 1574071889000}, "score": 29.932362, "issued": {"date-parts": [[2014, 12, 6]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2014, 12, 6]]}, "issue": "21"}, "URL": "http://dx.doi.org/10.1182/blood.v124.21.701.701", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T01:51:32Z", "timestamp": 1574473892207}, "reference-count": 9, "publisher": "American Society of Hematology", "issue": "18", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2012, 5, 3]]}, "DOI": "10.1182/blood-2012-02-405019", "type": "journal-article", "created": {"date-parts": [[2012, 5, 3]], "date-time": "2012-05-03T16:38:35Z", "timestamp": 1336063115000}, "page": "4335-4337", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Improved classification of MLL-AF9\u2013positive acute myeloid leukemia patients based on BRE and EVI1 expression"], "prefix": "10.1182", "volume": "119", "author": [{"given": "Sylvie M.", "family": "Noordermeer", "sequence": "first", "affiliation": [{"name": "Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands"}]}, {"given": "Davide", "family": "Monteferrario", "sequence": "additional", "affiliation": [{"name": "Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands"}]}, {"given": "Mathijs A.", "family": "Sanders", "sequence": "additional", "affiliation": [{"name": "Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands"}]}, {"given": "Lars", "family": "Bullinger", "sequence": "additional", "affiliation": [{"name": "Department of Internal Medicine III, University of Ulm, Ulm, Germany"}]}, {"given": "Joop H.", "family": "Jansen", "sequence": "additional", "affiliation": [{"name": "Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands"}]}, {"given": "Bert A.", "family": "van der Reijden", "sequence": "additional", "affiliation": [{"name": "Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands"}]}], "member": "234", "reference": [{"issue": "20", "key": "2019111807425914100_B1", "doi-asserted-by": "crossref", "first-page": "2758", "DOI": "10.1200/JCO.2010.32.8500", "article-title": "Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system.", "volume": "29", "author": "R\u00f6llig", "year": "2011", "journal-title": "J Clin Oncol"}, {"issue": "3", "key": "2019111807425914100_B2", "doi-asserted-by": "crossref", "first-page": "354", "DOI": "10.1182/blood-2009-11-254441", "article-title": "Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.", "volume": "116", "author": "Grimwade", "year": "2010", "journal-title": "Blood"}, {"issue": "20", "key": "2019111807425914100_B3", "doi-asserted-by": "crossref", "first-page": "5613", "DOI": "10.1182/blood-2011-06-359182", "article-title": "High BRE expression predicts favorable outcome in adult acute myeloid leukemia, in particular among MLL-AF9-positive patients.", "volume": "118", "author": "Noordermeer", "year": "2011", "journal-title": "Blood"}, {"issue": "12", "key": "2019111807425914100_B4", "doi-asserted-by": "crossref", "first-page": "2101", "DOI": "10.1200/JCO.2009.26.0646", "article-title": "High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.", "volume": "28", "author": "Gr\u00f6schel", "year": "2010", "journal-title": "J Clin Oncol"}, {"issue": "5", "key": "2019111807425914100_B5", "doi-asserted-by": "crossref", "first-page": "942", "DOI": "10.1038/leu.2010.47", "article-title": "EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia.", "volume": "24", "author": "Balgobind", "year": "2010", "journal-title": "Leukemia"}, {"issue": "23", "key": "2019111807425914100_B6", "doi-asserted-by": "crossref", "first-page": "6304", "DOI": "10.1182/blood-2009-07-234310", "article-title": "Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells.", "volume": "117", "author": "Arai", "year": "2011", "journal-title": "Blood"}, {"issue": "13", "key": "2019111807425914100_B7", "doi-asserted-by": "crossref", "first-page": "3088", "DOI": "10.1182/blood-2008-09-179895", "article-title": "Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome.", "volume": "113", "author": "Wouters", "year": "2009", "journal-title": "Blood"}, {"issue": "8", "key": "2019111807425914100_B8", "doi-asserted-by": "crossref", "first-page": "903", "DOI": "10.1038/nm.2187", "article-title": "Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia.", "volume": "16", "author": "Kharas", "year": "2010", "journal-title": "Nat Med"}, {"issue": "16", "key": "2019111807425914100_B9", "doi-asserted-by": "crossref", "first-page": "1617", "DOI": "10.1056/NEJMoa040465", "article-title": "Prognostically useful gene-expression profiles in acute myeloid leukemia.", "volume": "350", "author": "Valk", "year": "2004", "journal-title": "N Engl J Med"}], "container-title": ["Blood"], "language": "en", "link": [{"URL": "http://ashpublications.org/blood/article-pdf/119/18/4335/1353055/zh801812004335.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/blood/article-pdf/119/18/4335/1353055/zh801812004335.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T12:55:04Z", "timestamp": 1574081704000}, "score": 29.71771, "issued": {"date-parts": [[2012, 5, 3]]}, "references-count": 9, "journal-issue": {"published-print": {"date-parts": [[2012, 5, 3]]}, "issue": "18"}, "URL": "http://dx.doi.org/10.1182/blood-2012-02-405019", "relation": {"cites": []}, "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T23:13:45Z", "timestamp": 1574378025321}, "reference-count": 16, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2008, 7, 9]], "date-time": "2008-07-09T00:00:00Z", "timestamp": 1215561600000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["BMC Cancer"], "published-print": {"date-parts": [[2008, 12]]}, "DOI": "10.1186/1471-2407-8-193", "type": "journal-article", "created": {"date-parts": [[2008, 7, 9]], "date-time": "2008-07-09T18:13:49Z", "timestamp": 1215627229000}, "source": "Crossref", "is-referenced-by-count": 6, "title": ["EVI1activation in blast crisis CML due to juxtaposition to the rare 17q22 partner region as part of a 4-way variant translocation t(9;22)"], "prefix": "10.1186", "volume": "8", "author": [{"given": "An", "family": "De Weer", "sequence": "first", "affiliation": []}, {"given": "Bruce", "family": "Poppe", "sequence": "additional", "affiliation": []}, {"given": "Barbara", "family": "Cauwelier", "sequence": "additional", "affiliation": []}, {"given": "Andre", "family": "Carlier", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Dierick", "sequence": "additional", "affiliation": []}, {"given": "Bruno", "family": "Verhasselt", "sequence": "additional", "affiliation": []}, {"given": "Jan", "family": "Philipp\u00e9", "sequence": "additional", "affiliation": []}, {"given": "Nadine", "family": "Van Roy", "sequence": "additional", "affiliation": []}, {"given": "Frank", "family": "Speleman", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2008, 7, 9]]}, "reference": [{"issue": "15", "key": "1131_CR1", "doi-asserted-by": "publisher", "first-page": "1451", "DOI": "10.1056/NEJMra020777", "volume": "349", "author": "JM Goldman", "year": "2003", "unstructured": "Goldman JM, Melo JV: Chronic myeloid leukemia \u2013 advances in biology and new approaches to treatment. The New England journal of medicine. 2003, 349 (15): 1451-1464. 10.1056/NEJMra020777.", "journal-title": "The New England journal of medicine"}, {"issue": "2", "key": "1131_CR2", "doi-asserted-by": "publisher", "first-page": "76", "DOI": "10.1159/000046636", "volume": "107", "author": "B Johansson", "year": "2002", "unstructured": "Johansson B, Fioretos T, Mitelman F: Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta haematologica. 2002, 107 (2): 76-94. 10.1159/000046636.", "journal-title": "Acta haematologica"}, {"issue": "5", "key": "1131_CR3", "first-page": "788", "volume": "10", "author": "S Ogawa", "year": "1996", "unstructured": "Ogawa S, Kurokawa M, Tanaka T, Tanaka K, Hangaishi A, Mitani K, Kamada N, Yazaki Y, Hirai H: Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia. Leukemia. 1996, 10 (5): 788-794.", "journal-title": "Leukemia"}, {"key": "1131_CR4", "author": "S Lugthart", "year": "2008", "unstructured": "Lugthart S, Drunen EV, Norden YV, Hoven AV, Erpelinck CA, Valk PJ, Beverloo HB, Lowenberg B, Delwel R: High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. Blood. 2008", "volume-title": "Blood"}, {"issue": "2", "key": "1131_CR5", "doi-asserted-by": "publisher", "first-page": "206", "DOI": "10.1016/S1079-9796(03)00159-1", "volume": "31", "author": "S Buonamici", "year": "2003", "unstructured": "Buonamici S, Chakraborty S, Senyuk V, Nucifora G: The role of EVI1 in normal and leukemic cells. Blood cells, molecules & diseases. 2003, 31 (2): 206-212. 10.1016/S1079-9796(03)00159-1.", "journal-title": "Blood cells, molecules & diseases"}, {"key": "1131_CR6", "unstructured": "Shaffer L, Tommerup N, (eds): ISCN 2005: an international system for human cytogenetic nomenclature. 2005, Basel: S. Karger"}, {"issue": "1", "key": "1131_CR7", "doi-asserted-by": "publisher", "first-page": "60", "DOI": "10.1002/gcc.1212", "volume": "33", "author": "H Van Limbergen", "year": "2002", "unstructured": "Van Limbergen H, Poppe B, Michaux L, Herens C, Brown J, Noens L, Berneman Z, De Bock R, De Paepe A, Speleman F: Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH. Genes, chromosomes & cancer. 2002, 33 (1): 60-72. 10.1002/gcc.1212.", "journal-title": "Genes, chromosomes & cancer"}, {"issue": "2", "key": "1131_CR8", "doi-asserted-by": "publisher", "first-page": "113", "DOI": "10.1002/gcc.10034", "volume": "35", "author": "N Van Roy", "year": "2002", "unstructured": "Van Roy N, Vandesompele J, Berx G, Staes K, Van Gele M, De Smet E, De Paepe A, Laureys G, Drift van der P, Versteeg R, et al: Localization of the 17q breakpoint of a constitutional 1;17 translocation in a patient with neuroblastoma within a 25-kb segment located between the ACCN1 and TLK2 genes and near the distal breakpoints of two microdeletions in neurofibromatosis type 1 patients. Genes, chromosomes & cancer. 2002, 35 (2): 113-120. 10.1002/gcc.10034.", "journal-title": "Genes, chromosomes & cancer"}, {"issue": "4", "key": "1131_CR9", "doi-asserted-by": "publisher", "first-page": "349", "DOI": "10.1002/gcc.20295", "volume": "45", "author": "B Poppe", "year": "2006", "unstructured": "Poppe B, Dastugue N, Vandesompele J, Cauwelier B, De Smet B, Yigit N, De Paepe A, Cervera J, Recher C, De Mas V, et al: EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements. Genes, chromosomes & cancer. 2006, 45 (4): 349-356. 10.1002/gcc.20295.", "journal-title": "Genes, chromosomes & cancer"}, {"issue": "7", "key": "1131_CR10", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1186/gb-2002-3-7-research0034", "volume": "3", "author": "J Vandesompele", "year": "2002", "unstructured": "Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome biology. 2002, 3 (7): 1-11. 10.1186/gb-2002-3-7-research0034.", "journal-title": "Genome biology"}, {"issue": "12", "key": "1131_CR11", "doi-asserted-by": "publisher", "first-page": "2318", "DOI": "10.1038/sj.leu.2403135", "volume": "17", "author": "J Gabert", "year": "2003", "unstructured": "Gabert J, Beillard E, Velden van der VH, Bi W, Grimwade D, Pallisgaard N, Barbany G, Cazzaniga G, Cayuela JM, Cave H, et al: Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia \u2013 a Europe Against Cancer program. Leukemia. 2003, 17 (12): 2318-2357. 10.1038/sj.leu.2403135.", "journal-title": "Leukemia"}, {"issue": "2", "key": "1131_CR12", "doi-asserted-by": "publisher", "first-page": "97", "DOI": "10.1016/j.cancergencyto.2006.10.006", "volume": "173", "author": "M Gorusu", "year": "2007", "unstructured": "Gorusu M, Benn P, Li Z, Fang M: On the genesis and prognosis of variant translocations in chronic myeloid leukemia. Cancer genetics and cytogenetics. 2007, 173 (2): 97-106. 10.1016/j.cancergencyto.2006.10.006.", "journal-title": "Cancer genetics and cytogenetics"}, {"issue": "3", "key": "1131_CR13", "doi-asserted-by": "publisher", "first-page": "837", "DOI": "10.1182/blood-2002-05-1459", "volume": "101", "author": "S van Waalwijk van Doorn-Khosrovani Barjesteh", "year": "2003", "unstructured": "Barjesteh van Waalwijk van Doorn-Khosrovani S, Erpelinck C, van Putten WL, Valk PJ, Poel-van de Luytgaarde van der S, Hack R, Slater R, Smit EM, Beverloo HB, Verhoef G, et al: High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood. 2003, 101 (3): 837-845. 10.1182/blood-2002-05-1459.", "journal-title": "Blood"}, {"issue": "4", "key": "1131_CR14", "doi-asserted-by": "publisher", "first-page": "288", "DOI": "10.1002/gcc.20532", "volume": "47", "author": "K Haas", "year": "2008", "unstructured": "Haas K, Kundi M, Sperr WR, Esterbauer H, Ludwig WD, Ratei R, Koller E, Gruener H, Sauerland C, Fonatsch C, et al: Expression and prognostic significance of different mRNA 5'-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission duration. Genes Chromosomes Cancer. 2008, 47 (4): 288-298. 10.1002/gcc.20532.", "journal-title": "Genes Chromosomes Cancer"}, {"issue": "1", "key": "1131_CR15", "doi-asserted-by": "publisher", "first-page": "99", "DOI": "10.1586/14737140.8.1.99", "volume": "8", "author": "E Jabbour", "year": "2008", "unstructured": "Jabbour E, Cortes JE, Ghanem H, O'Brien S, Kantarjian HM: Targeted therapy in chronic myeloid leukemia. Expert Rev Anticancer Ther. 2008, 8 (1): 99-110. 10.1586/14737140.8.1.99.", "journal-title": "Expert Rev Anticancer Ther"}, {"issue": "2", "key": "1131_CR16", "doi-asserted-by": "publisher", "first-page": "346", "DOI": "10.1016/j.gene.2007.04.012", "volume": "396", "author": "R Wieser", "year": "2007", "unstructured": "Wieser R: The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions. Gene. 2007, 396 (2): 346-357. 10.1016/j.gene.2007.04.012.", "journal-title": "Gene"}], "container-title": ["BMC Cancer"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/1471-2407-8-193.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1186/1471-2407-8-193/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1186/1471-2407-8-193", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 7, 9]], "date-time": "2016-07-09T13:12:59Z", "timestamp": 1468069979000}, "score": 29.0158, "issued": {"date-parts": [[2008, 7, 9]]}, "references-count": 16, "journal-issue": {"published-print": {"date-parts": [[2008, 12]]}, "issue": "1"}, "alternative-id": ["1131"], "URL": "http://dx.doi.org/10.1186/1471-2407-8-193", "relation": {"cites": []}, "ISSN": ["1471-2407"], "issn-type": [{"value": "1471-2407", "type": "electronic"}], "article-number": "193"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T05:45:25Z", "timestamp": 1574487925234}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1999, 3, 1]], "date-time": "1999-03-01T00:00:00Z", "timestamp": 920246400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[1999, 3]]}, "DOI": "10.1038/sj.leu.2401360", "type": "journal-article", "created": {"date-parts": [[2011, 1, 7]], "date-time": "2011-01-07T16:21:46Z", "timestamp": 1294417306000}, "page": "348-357", "source": "Crossref", "is-referenced-by-count": 68, "title": ["MDS1/EVI1 enhances TGF-\u03b21 signaling and strengthens its growth-inhibitory effect, but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-\u03b21"], "prefix": "10.1038", "volume": "13", "author": [{"given": "R", "family": "Sood", "sequence": "first", "affiliation": []}, {"given": "A", "family": "Talwar-Trikha", "sequence": "additional", "affiliation": []}, {"given": "SR", "family": "Chakrabarti", "sequence": "additional", "affiliation": []}, {"given": "G", "family": "Nucifora", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[1999, 3, 10]]}, "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/2401360.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2401360", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2401360.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T07:02:57Z", "timestamp": 1552719777000}, "score": 28.932335, "issued": {"date-parts": [[1999, 3]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1999, 3]]}, "issue": "3"}, "alternative-id": ["BF2401360"], "URL": "http://dx.doi.org/10.1038/sj.leu.2401360", "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T13:03:59Z", "timestamp": 1575464639350}, "reference-count": 10, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2014, 4, 1]], "date-time": "2014-04-01T00:00:00Z", "timestamp": 1396310400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "https://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2015, 4, 14]], "date-time": "2015-04-14T00:00:00Z", "timestamp": 1428969600000}, "delay-in-days": 378, "content-version": "vor"}], "content-domain": {"domain": ["cancercell.org", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Cancer Cell"], "published-print": {"date-parts": [[2014, 4]]}, "DOI": "10.1016/j.ccr.2014.03.031", "type": "journal-article", "created": {"date-parts": [[2014, 4, 14]], "date-time": "2014-04-14T15:45:39Z", "timestamp": 1397490339000}, "page": "407-408", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Genomic Dark Matter Sheds Light on EVI1-Driven Leukemia"], "prefix": "10.1016", "volume": "25", "author": [{"given": "Richard\u00a0P.", "family": "Koche", "sequence": "first", "affiliation": []}, {"given": "Scott\u00a0A.", "family": "Armstrong", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Cancer Cell"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1535610814001317?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1535610814001317?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 4]], "date-time": "2018-10-04T23:53:33Z", "timestamp": 1538697213000}, "score": 28.608017, "issued": {"date-parts": [[2014, 4]]}, "references-count": 10, "journal-issue": {"published-print": {"date-parts": [[2014, 4]]}, "issue": "4"}, "alternative-id": ["S1535610814001317"], "URL": "http://dx.doi.org/10.1016/j.ccr.2014.03.031", "ISSN": ["1535-6108"], "issn-type": [{"value": "1535-6108", "type": "print"}], "subject": ["Cell Biology", "Cancer Research", "Oncology"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Genomic Dark Matter Sheds Light on EVI1-Driven Leukemia", "name": "articletitle", "label": "Article Title"}, {"value": "Cancer Cell", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.ccr.2014.03.031", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "https://doi.org/10.1016/j.ccr.2014.02.008", "name": "associatedlink", "label": "CrossRef DOI link to the associated document"}, {"value": "https://doi.org/10.1016/j.cell.2014.02.019", "name": "associatedlink", "label": "CrossRef DOI link to the associated document"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2014 Elsevier Inc. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T20:06:07Z", "timestamp": 1574798767245}, "reference-count": 0, "publisher": "Informa UK Limited", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Acta Clinica Belgica"], "published-print": {"date-parts": [[1962, 1]]}, "DOI": "10.1080/17843286.1962.11717718", "type": "journal-article", "created": {"date-parts": [[2016, 5, 20]], "date-time": "2016-05-20T01:45:41Z", "timestamp": 1463708741000}, "page": "416-436", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Donnees Recentes Sur Quelques Anemies Hemolytiques Constitutionnelles"], "prefix": "10.1080", "volume": "17", "author": [{"given": "A.", "family": "de Weer", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2016, 5, 19]]}, "container-title": ["Acta Clinica Belgica"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1080/17843286.1962.11717718", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 10]], "date-time": "2016-12-10T16:12:44Z", "timestamp": 1481386364000}, "score": 28.250555, "issued": {"date-parts": [[1962, 1]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016, 5, 19]]}, "published-print": {"date-parts": [[1962, 1]]}, "issue": "5"}, "alternative-id": ["10.1080/17843286.1962.11717718"], "URL": "http://dx.doi.org/10.1080/17843286.1962.11717718", "ISSN": ["1784-3286", "2295-3337"], "issn-type": [{"value": "1784-3286", "type": "print"}, {"value": "2295-3337", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T03:42:15Z", "timestamp": 1574566935901}, "reference-count": 0, "publisher": "INIST-CNRS", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.4267/2042/54377", "type": "journal-article", "created": {"date-parts": [[2014, 12, 9]], "date-time": "2014-12-09T13:51:56Z", "timestamp": 1418133116000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["t(3;12)(q26;p13) ETV6/MECOM - t(3;12)(q26;p13) ETV6/EVI1"], "prefix": "10.4267", "author": [{"given": "Braekeleer E", "family": "De", "sequence": "first", "affiliation": []}, {"given": "N", "family": "Douet-Guilbert", "sequence": "additional", "affiliation": []}, {"given": "Braekeleer M", "family": "De", "sequence": "additional", "affiliation": []}], "member": "2793", "published-online": {"date-parts": [[2014, 11]]}, "container-title": ["Atlas of Genetics and Cytogenetics in Oncology and Haematology"], "deposited": {"date-parts": [[2014, 12, 9]], "date-time": "2014-12-09T13:52:08Z", "timestamp": 1418133128000}, "score": 27.487558, "issued": {"date-parts": [[2014, 11]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2014, 11]]}, "issue": "12"}, "URL": "http://dx.doi.org/10.4267/2042/54377", "ISSN": ["1768-3262"], "issn-type": [{"value": "1768-3262", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T01:28:37Z", "timestamp": 1574731717031}, "reference-count": 31, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["wiley.com"], "crossmark-restriction": true}, "short-container-title": ["Int. Jnl. Lab. Hem."], "published-print": {"date-parts": [[2016, 2]]}, "DOI": "10.1111/ijlh.12435", "type": "journal-article", "created": {"date-parts": [[2015, 9, 29]], "date-time": "2015-09-29T15:12:28Z", "timestamp": 1443539548000}, "page": "64-71", "update-policy": "http://dx.doi.org/10.1002/crossmark_policy", "source": "Crossref", "is-referenced-by-count": 3, "title": ["NUP98-HOXA9bearing therapy-related myeloid neoplasm involves myeloid-committed cell and inducesHOXA5,EVI1, FLT3,andMEIS1expression"], "prefix": "10.1111", "volume": "38", "author": [{"ORCID": "http://orcid.org/0000-0002-6895-7875", "authenticated-orcid": false, "given": "S.", "family": "Burillo-Sanz", "sequence": "first", "affiliation": [{"name": "Servicio de Inmunolog\u00eda; Hospital Universitario Virgen del Roc\u00edo; Sevilla Spain"}]}, {"given": "R. M.", "family": "Morales-Camacho", "sequence": "additional", "affiliation": [{"name": "Department of Hematology; Instituto de Biomedicina de Sevilla (IBIS)/Hospital Universitario Virgen del Roc\u00edo/CSIC/Universidad de Sevilla; Sevilla Spain"}]}, {"given": "T.", "family": "Caballero-Vel\u00e1zquez", "sequence": "additional", "affiliation": [{"name": "Department of Hematology; Instituto de Biomedicina de Sevilla (IBIS)/Hospital Universitario Virgen del Roc\u00edo/CSIC/Universidad de Sevilla; Sevilla Spain"}]}, {"given": "M. T.", "family": "Vargas", "sequence": "additional", "affiliation": [{"name": "Department of Hematology; Instituto de Biomedicina de Sevilla (IBIS)/Hospital Universitario Virgen del Roc\u00edo/CSIC/Universidad de Sevilla; Sevilla Spain"}]}, {"given": "J. R.", "family": "Garc\u00eda-Lozano", "sequence": "additional", "affiliation": [{"name": "Servicio de Inmunolog\u00eda; Hospital Universitario Virgen del Roc\u00edo; Sevilla Spain"}]}, {"given": "J. F.", "family": "Falantes", "sequence": "additional", "affiliation": [{"name": "Department of Hematology; Instituto de Biomedicina de Sevilla (IBIS)/Hospital Universitario Virgen del Roc\u00edo/CSIC/Universidad de Sevilla; Sevilla Spain"}]}, {"given": "C.", "family": "Prats-Mart\u00edn", "sequence": "additional", "affiliation": [{"name": "Department of Hematology; Instituto de Biomedicina de Sevilla (IBIS)/Hospital Universitario Virgen del Roc\u00edo/CSIC/Universidad de Sevilla; Sevilla Spain"}]}, {"given": "R.", "family": "Bernal", "sequence": "additional", "affiliation": [{"name": "Department of Hematology; Instituto de Biomedicina de Sevilla (IBIS)/Hospital Universitario Virgen del Roc\u00edo/CSIC/Universidad de Sevilla; Sevilla Spain"}]}, {"given": "J. A.", "family": "P\u00e9rez-Sim\u00f3n", "sequence": "additional", "affiliation": [{"name": "Department of Hematology; Instituto de Biomedicina de Sevilla (IBIS)/Hospital Universitario Virgen del Roc\u00edo/CSIC/Universidad de Sevilla; Sevilla Spain"}]}], "member": "311", "published-online": {"date-parts": [[2015, 9, 29]]}, "reference": [{"key": "10.1111/ijlh.12435-BIB0001|ijlh12435-cit-0001", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1038/ng0296-159", "article-title": "The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9", "volume": "12", "author": "Borrow", "year": "1996", "journal-title": "Nat Genet"}, {"key": "10.1111/ijlh.12435-BIB0002|ijlh12435-cit-0002", "doi-asserted-by": "crossref", "first-page": "154", "DOI": "10.1038/ng0296-154", "article-title": "Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia", "volume": "12", "author": "Nakamura", "year": "1996", "journal-title": "Nat Genet"}, {"key": "10.1111/ijlh.12435-BIB0003|ijlh12435-cit-0003", "doi-asserted-by": "crossref", "first-page": "1303", "DOI": "10.1038/leu.2009.25", "article-title": "Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients", "volume": "23", "author": "Chou", "year": "2009", "journal-title": "Leukemia"}, {"key": "10.1111/ijlh.12435-BIB0004|ijlh12435-cit-0004", "doi-asserted-by": "crossref", "first-page": "1010", "DOI": "10.1016/j.leukres.2013.05.020", "article-title": "Clinical and laboratory studies of 17 patients with acute myeloid leukemia harboring t(7;11)(p15;p15) translocation", "volume": "37", "author": "Wei", "year": "2013", "journal-title": "Leuk Res"}, {"key": "10.1111/ijlh.12435-BIB0005|ijlh12435-cit-0005", "doi-asserted-by": "crossref", "first-page": "114", "DOI": "10.1196/annals.1392.019", "article-title": "NUP98 dysregulation in myeloid leukemogenesis", "volume": "1106", "author": "Moore", "year": "2007", "journal-title": "Ann N Y Acad Sci"}, {"key": "10.1111/ijlh.12435-BIB0006|ijlh12435-cit-0006", "doi-asserted-by": "crossref", "first-page": "96", "DOI": "10.1002/1098-2264(2000)9999:9999<::AID-GCC1013>3.0.CO;2-T", "article-title": "Potential role for DNA topoisomerase II poisons in the generation of t(11;20)(p15;q11) translocations", "volume": "29", "author": "Ahuja", "year": "2000", "journal-title": "Genes Chromosom Cancer"}, {"key": "10.1111/ijlh.12435-BIB0007|ijlh12435-cit-0007", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1093/oxfordjournals.annonc.a058121", "article-title": "Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genes", "volume": "3", "author": "Ratain", "year": "1992", "journal-title": "Ann Oncol"}, {"key": "10.1111/ijlh.12435-BIB0008|ijlh12435-cit-0008", "doi-asserted-by": "crossref", "first-page": "1689", "DOI": "10.1038/sj.leu.2402269", "article-title": "NUP98 gene fusions in hematologic malignancies", "volume": "15", "author": "Lam", "year": "2001", "journal-title": "Leukemia"}, {"key": "10.1111/ijlh.12435-BIB0009|ijlh12435-cit-0009", "doi-asserted-by": "crossref", "first-page": "6247", "DOI": "10.1182/blood-2011-07-328880", "article-title": "NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights", "volume": "118", "author": "Gough", "year": "2011", "journal-title": "Blood"}, {"key": "10.1111/ijlh.12435-BIB0010|ijlh12435-cit-0010", "doi-asserted-by": "crossref", "first-page": "6628", "DOI": "10.1158/0008-5472.CAN-06-0458", "article-title": "NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34 + hematopoietic cells", "volume": "66", "author": "Takeda", "year": "2006", "journal-title": "Cancer Res"}, {"key": "10.1111/ijlh.12435-BIB0011|ijlh12435-cit-0011", "doi-asserted-by": "crossref", "first-page": "4247", "DOI": "10.1038/sj.onc.1205516", "article-title": "Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1", "volume": "21", "author": "Calvo", "year": "2002", "journal-title": "Oncogene"}, {"key": "10.1111/ijlh.12435-BIB0012|ijlh12435-cit-0012", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1007/s12185-009-0267-8", "article-title": "Enhanced expression of the EVI1 gene in NUP98/HOXA-expressing leukemia cells", "volume": "89", "author": "Eguchi-Ishimae", "year": "2009", "journal-title": "Int J Hematol"}, {"key": "10.1111/ijlh.12435-BIB0013|ijlh12435-cit-0013", "doi-asserted-by": "crossref", "first-page": "1030", "DOI": "10.1182/blood-2005-12-007005", "article-title": "The Flt3 receptor tyrosine kinase collaborates with NUP98-HOX fusions in acute myeloid leukemia", "volume": "108", "author": "Palmqvist", "year": "2006", "journal-title": "Blood"}, {"key": "10.1111/ijlh.12435-BIB0014|ijlh12435-cit-0014", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1016/j.cancergencyto.2004.08.001", "article-title": "NUP98 is fused to HOXA9 in a variant complex t(7;11;13;17) in a patient with AML-M2", "volume": "157", "author": "Lahortiga", "year": "2005", "journal-title": "Cancer Genet Cytogenet"}, {"key": "10.1111/ijlh.12435-BIB0015|ijlh12435-cit-0015", "doi-asserted-by": "crossref", "first-page": "696", "DOI": "10.1038/sj.leu.2404130", "article-title": "NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogenetique Hematologique", "volume": "20", "author": "Romana", "year": "2006", "journal-title": "Leukemia"}, {"key": "10.1111/ijlh.12435-BIB0016|ijlh12435-cit-0016", "unstructured": "Shaffer LG Schmid M An International System for Human Cytogenetic Nomenclature (2013)."}, {"key": "10.1111/ijlh.12435-BIB0017|ijlh12435-cit-0017", "doi-asserted-by": "crossref", "first-page": "682", "DOI": "10.1046/j.1365-2141.1997.d01-2100.x", "article-title": "Clinical, haematological and molecular studies in patients with chromosome translocation t(7;11): a study of four Chinese patients in Taiwan", "volume": "96", "author": "Huang", "year": "1997", "journal-title": "Br J Haematol"}, {"key": "10.1111/ijlh.12435-BIB0018|ijlh12435-cit-0018", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1002/(SICI)1098-2264(199905)25:1<70::AID-GCC11>3.0.CO;2-E", "article-title": "Low frequency of rearrangements of the homeobox gene HOXA9/t(7;11) in adult acute myeloid leukemia", "volume": "25", "author": "Kwong", "year": "1999", "journal-title": "Genes Chromosom Cancer"}, {"key": "10.1111/ijlh.12435-BIB0019|ijlh12435-cit-0019", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1016/j.cancergen.2014.10.006", "article-title": "A new rearrangement giving rise to a very rare MLL-MLLT10 fusion mRNA in an infant acute myeloid leukemia", "volume": "208", "author": "Burillo-Sanz", "year": "2015", "journal-title": "Cancer Genet"}, {"key": "10.1111/ijlh.12435-BIB0020|ijlh12435-cit-0020", "doi-asserted-by": "crossref", "first-page": "402", "DOI": "10.1006/meth.2001.1262", "article-title": "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method", "volume": "25", "author": "Livak", "year": "2001", "journal-title": "Methods"}, {"key": "10.1111/ijlh.12435-BIB0021|ijlh12435-cit-0021", "doi-asserted-by": "crossref", "first-page": "837", "DOI": "10.1182/blood-2002-05-1459", "article-title": "High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients", "volume": "101", "author": "Barjesteh van Waalwijk van Doorn-Khosrovani", "year": "2003", "journal-title": "Blood"}, {"key": "10.1111/ijlh.12435-BIB0022|ijlh12435-cit-0022", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.1002/gcc.20092", "article-title": "Analysis of translocations that involve the NUP98 gene in patients with 11p15 chromosomal rearrangements", "volume": "41", "author": "Kobzev", "year": "2004", "journal-title": "Genes Chromosom Cancer"}, {"key": "10.1111/ijlh.12435-BIB0023|ijlh12435-cit-0023", "doi-asserted-by": "crossref", "first-page": "767", "DOI": "10.1038/sj.leu.2403688", "article-title": "Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries", "volume": "19", "author": "Chen", "year": "2005", "journal-title": "Leukemia"}, {"key": "10.1111/ijlh.12435-BIB0024|ijlh12435-cit-0024", "doi-asserted-by": "crossref", "first-page": "70", "DOI": "10.1016/S0165-4608(99)00085-0", "article-title": "Chronic myelomonocytic leukemia with t(7;11)(p15;p15) and NUP98/HOXA9 fusion", "volume": "115", "author": "Wong", "year": "1999", "journal-title": "Cancer Genet Cytogenet"}, {"key": "10.1111/ijlh.12435-BIB0025|ijlh12435-cit-0025", "doi-asserted-by": "crossref", "first-page": "657", "DOI": "10.1002/ijc.2910360606", "article-title": "Possible association of a new translocation, t(7;11)(p15;p15), with Ph1 chromosome-negative chronic myelogenous leukemia", "volume": "36", "author": "Kaneko", "year": "1985", "journal-title": "Int J Cancer"}, {"key": "10.1111/ijlh.12435-BIB0026|ijlh12435-cit-0026", "first-page": "1654", "article-title": "Reciprocal translocation involving the short arms of chromosomes 7 and 11, t(7p-;11p+), associated with myeloid leukemia with maturation", "volume": "70", "author": "Sato", "year": "1987", "journal-title": "Blood"}, {"key": "10.1111/ijlh.12435-BIB0027|ijlh12435-cit-0027", "first-page": "640", "article-title": "Late appearance of a Philadelphia translocation with minor-BCR/ABL transcript in a t(7;11)(p15;p15) acute myeloid leukemia", "volume": "9", "author": "Shimamoto", "year": "1995", "journal-title": "Leukemia"}, {"key": "10.1111/ijlh.12435-BIB0028|ijlh12435-cit-0028", "doi-asserted-by": "crossref", "first-page": "e6719", "DOI": "10.1371/journal.pone.0006719", "article-title": "Dissection of the transformation of primary human hematopoietic cells by the oncogene NUP98-HOXA9", "volume": "4", "author": "Yassin", "year": "2009", "journal-title": "PLoS ONE"}, {"key": "10.1111/ijlh.12435-BIB0029|ijlh12435-cit-0029", "doi-asserted-by": "crossref", "first-page": "545", "DOI": "10.1016/j.leukres.2010.10.006", "article-title": "Delineating domains and functions of NUP98 contributing to the leukemogenic activity of NUP98-HOX fusions", "volume": "35", "author": "Yung", "year": "2011", "journal-title": "Leuk Res"}, {"key": "10.1111/ijlh.12435-BIB0030|ijlh12435-cit-0030", "doi-asserted-by": "crossref", "first-page": "777", "DOI": "10.1038/nrc907", "article-title": "Deregulated homeobox gene expression in cancer: cause or consequence?", "volume": "2", "author": "Abate-Shen", "year": "2002", "journal-title": "Nat Rev Cancer"}, {"key": "10.1111/ijlh.12435-BIB0031|ijlh12435-cit-0031", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.1002/(SICI)1098-2264(199911)26:3<215::AID-GCC5>3.0.CO;2-1", "article-title": "11p15 translocations involving the NUP98 gene in childhood therapy-related acute myeloid leukemia/myelodysplastic syndrome", "volume": "26", "author": "Nishiyama", "year": "1999", "journal-title": "Genes Chromosom Cancer"}], "container-title": ["International Journal of Laboratory Hematology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fijlh.12435", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 23]], "date-time": "2017-06-23T20:26:34Z", "timestamp": 1498249594000}, "score": 26.838457, "issued": {"date-parts": [[2015, 9, 29]]}, "references-count": 31, "journal-issue": {"published-print": {"date-parts": [[2016, 2]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1111/ijlh.12435", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["1751-5521"], "issn-type": [{"value": "1751-5521", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T11:16:25Z", "timestamp": 1574421385106}, "reference-count": 50, "publisher": "Springer Science and Business Media LLC", "issue": "5", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2010, 4, 1]], "date-time": "2010-04-01T00:00:00Z", "timestamp": 1270080000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[2010, 5]]}, "DOI": "10.1038/leu.2010.47", "type": "journal-article", "created": {"date-parts": [[2010, 4, 1]], "date-time": "2010-04-01T09:44:57Z", "timestamp": 1270115097000}, "page": "942-949", "source": "Crossref", "is-referenced-by-count": 40, "title": ["EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia"], "prefix": "10.1038", "volume": "24", "author": [{"given": "B V", "family": "Balgobind", "sequence": "first", "affiliation": []}, {"given": "S", "family": "Lugthart", "sequence": "additional", "affiliation": []}, {"given": "I H", "family": "Hollink", "sequence": "additional", "affiliation": []}, {"given": "S T J C M", "family": "Arentsen-Peters", "sequence": "additional", "affiliation": []}, {"given": "E R", "family": "van Wering", "sequence": "additional", "affiliation": []}, {"given": "S S N", "family": "de Graaf", "sequence": "additional", "affiliation": []}, {"given": "D", "family": "Reinhardt", "sequence": "additional", "affiliation": []}, {"given": "U", "family": "Creutzig", "sequence": "additional", "affiliation": []}, {"given": "G J L", "family": "Kaspers", "sequence": "additional", "affiliation": []}, {"given": "E S J M", "family": "de Bont", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Stary", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Trka", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "Zimmermann", "sequence": "additional", "affiliation": []}, {"given": "H B", "family": "Beverloo", "sequence": "additional", "affiliation": []}, {"given": "R", "family": "Pieters", "sequence": "additional", "affiliation": []}, {"given": "R", "family": "Delwel", "sequence": "additional", "affiliation": []}, {"given": "C M", "family": "Zwaan", "sequence": "additional", "affiliation": []}, {"given": "M M", "family": "van den Heuvel-Eibrink", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 4, 1]]}, "reference": [{"key": "BFleu201047_CR1", "doi-asserted-by": "publisher", "first-page": "346", "DOI": "10.1016/j.gene.2007.04.012", "volume": "396", "author": "R Wieser", "year": "2007", "unstructured": "Wieser R . The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions. Gene 2007; 396: 346\u2013357.", "journal-title": "Gene"}, {"key": "BFleu201047_CR2", "doi-asserted-by": "publisher", "first-page": "3937", "DOI": "10.1073/pnas.89.9.3937", "volume": "89", "author": "K Morishita", "year": "1992", "unstructured": "Morishita K, Parganas E, William CL, Whittaker MH, Drabkin H, Oval J et al. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26. Proc Natl Acad Sci USA 1992; 89: 3937\u20133941.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFleu201047_CR3", "doi-asserted-by": "publisher", "first-page": "1259", "DOI": "10.1128/MCB.10.3.1259", "volume": "10", "author": "T Matsugi", "year": "1990", "unstructured": "Matsugi T, Morishita K, Ihle JN . Identification, nuclear localization, and DNA-binding activity of the zinc finger protein encoded by the Evi-1 myeloid transforming gene. Mol Cell Biol 1990; 10: 1259\u20131264.", "journal-title": "Mol Cell Biol"}, {"key": "BFleu201047_CR4", "doi-asserted-by": "publisher", "first-page": "55", "DOI": "10.1016/S0925-4773(97)00057-9", "volume": "65", "author": "PR Hoyt", "year": "1997", "unstructured": "Hoyt PR, Bartholomew C, Davis AJ, Yutzey K, Gamer LW, Potter SS et al. The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development. Mech Dev 1997; 65: 55\u201370.", "journal-title": "Mech Dev"}, {"key": "BFleu201047_CR5", "doi-asserted-by": "publisher", "first-page": "831", "DOI": "10.1016/S0092-8674(88)91175-0", "volume": "54", "author": "K Morishita", "year": "1988", "unstructured": "Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NG, Ihle JN . Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 1988; 54: 831\u2013840.", "journal-title": "Cell"}, {"key": "BFleu201047_CR6", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/j.gene.2005.09.020", "volume": "368", "author": "G Nucifora", "year": "2006", "unstructured": "Nucifora G, Laricchia-Robbio L, Senyuk V . EVI1 and hematopoietic disorders: history and perspectives. Gene 2006; 368: 1\u201311.", "journal-title": "Gene"}, {"key": "BFleu201047_CR7", "doi-asserted-by": "publisher", "first-page": "2761", "DOI": "10.1016/j.febslet.2008.06.056", "volume": "582", "author": "D Spensberger", "year": "2008", "unstructured": "Spensberger D, Delwel R . A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a. FEBS Lett 2008; 582: 2761\u20132767.", "journal-title": "FEBS Lett"}, {"key": "BFleu201047_CR8", "doi-asserted-by": "publisher", "first-page": "344", "DOI": "10.1002/jcb.21869", "volume": "105", "author": "F Cattaneo", "year": "2008", "unstructured": "Cattaneo F, Nucifora G . EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression. J Cell Biochem 2008; 105: 344\u2013352.", "journal-title": "J Cell Biochem"}, {"key": "BFleu201047_CR9", "doi-asserted-by": "publisher", "first-page": "160", "DOI": "10.1016/j.gene.2005.04.032", "volume": "356", "author": "M Aytekin", "year": "2005", "unstructured": "Aytekin M, Vinatzer U, Musteanu M, Raynaud S, Wieser R . Regulation of the expression of the oncogene EVI1 through the use of alternative mRNA 5\u2032-ends. Gene 2005; 356: 160\u2013168.", "journal-title": "Gene"}, {"key": "BFleu201047_CR10", "doi-asserted-by": "publisher", "first-page": "1642", "DOI": "10.1073/pnas.93.4.1642", "volume": "93", "author": "S Fears", "year": "1996", "unstructured": "Fears S, Mathieu C, Zeleznik-Le N, Huang S, Rowley JD, Nucifora G . Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family. Proc Natl Acad Sci USA 1996; 93: 1642\u20131647.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFleu201047_CR11", "doi-asserted-by": "publisher", "first-page": "15933", "DOI": "10.1074/jbc.273.26.15933", "volume": "273", "author": "S Huang", "year": "1998", "unstructured": "Huang S, Shao G, Liu L . The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression. J Biol Chem 1998; 273: 15933\u201315939.", "journal-title": "J Biol Chem"}, {"key": "BFleu201047_CR12", "doi-asserted-by": "publisher", "first-page": "837", "DOI": "10.1182/blood-2002-05-1459", "volume": "101", "author": "S Barjesteh van Waalwijk van Doorn-Kh", "year": "2003", "unstructured": "Barjesteh van Waalwijk van Doorn-Khosrovani S, Erpelinck C, van Putten WL, Valk PJ, van der Poel-van de Luytgaarde S, Hack R et al. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood 2003; 101: 837\u2013845.", "journal-title": "Blood"}, {"key": "BFleu201047_CR13", "doi-asserted-by": "publisher", "first-page": "4329", "DOI": "10.1182/blood-2007-10-119230", "volume": "111", "author": "S Lugthart", "year": "2008", "unstructured": "Lugthart S, van Drunen E, van Norden Y, van Hoven A, Erpelinck CA, Valk PJ et al. High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. Blood 2008; 111: 4329\u20134337.", "journal-title": "Blood"}, {"key": "BFleu201047_CR14", "first-page": "3707", "volume": "94", "author": "SC Raimondi", "year": "1999", "unstructured": "Raimondi SC, Chang MN, Ravindranath Y, Behm FG, Gresik MV, Steuber CP et al. Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821. Blood 1999; 94: 3707\u20133716.", "journal-title": "Blood"}, {"key": "BFleu201047_CR15", "doi-asserted-by": "publisher", "first-page": "2292", "DOI": "10.1182/blood-2002-04-1199", "volume": "100", "author": "JW Vardiman", "year": "2002", "unstructured": "Vardiman JW, Harris NL, Brunning RD . The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292\u20132302.", "journal-title": "Blood"}, {"key": "BFleu201047_CR16", "doi-asserted-by": "publisher", "first-page": "2063", "DOI": "10.1038/sj.leu.2403873", "volume": "19", "author": "G Kardos", "year": "2005", "unstructured": "Kardos G, Zwaan CM, Kaspers GJ, de-Graaf SS, de Bont ES, Postma A et al. Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials. Leukemia 2005; 19: 2063\u20132071.", "journal-title": "Leukemia"}, {"key": "BFleu201047_CR17", "doi-asserted-by": "publisher", "first-page": "2130", "DOI": "10.1038/sj.leu.2403924", "volume": "19", "author": "BE Gibson", "year": "2005", "unstructured": "Gibson BE, Wheatley K, Hann IM, Stevens RF, Webb D, Hills RK et al. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia 2005; 19: 2130\u20132138.", "journal-title": "Leukemia"}, {"key": "BFleu201047_CR18", "doi-asserted-by": "publisher", "first-page": "2030", "DOI": "10.1038/sj.leu.2403920", "volume": "19", "author": "U Creutzig", "year": "2005", "unstructured": "Creutzig U, Zimmermann M, Ritter J, Reinhardt D, Hermann J, Henze G et al. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia 2005; 19: 2030\u20132042.", "journal-title": "Leukemia"}, {"key": "BFleu201047_CR19", "doi-asserted-by": "publisher", "first-page": "3262", "DOI": "10.1200/JCO.2003.11.031", "volume": "21", "author": "ML Den Boer", "year": "2003", "unstructured": "Den Boer ML, Harms DO, Pieters R, Kazemier KM, Gobel U, Korholz D et al. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. J Clin Oncol 2003; 21: 3262\u20133268.", "journal-title": "J Clin Oncol"}, {"key": "BFleu201047_CR20", "doi-asserted-by": "publisher", "first-page": "3520", "DOI": "10.1182/blood-2006-04-019927", "volume": "108", "author": "P Van Vlierberghe", "year": "2006", "unstructured": "Van Vlierberghe P, van Grotel M, Beverloo HB, Lee C, Helgason T, Buijs-Gladdines J et al. The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Blood 2006; 108: 3520\u20133529.", "journal-title": "Blood"}, {"key": "BFleu201047_CR21", "doi-asserted-by": "publisher", "first-page": "4322", "DOI": "10.1182/blood-2007-06-095075", "volume": "111", "author": "BV Balgobind", "year": "2008", "unstructured": "Balgobind BV, Van Vlierberghe P, van den Ouweland AM, Beverloo HB, Terlouw-Kromosoeto JN, van Wering ER et al. Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis. Blood 2008; 111: 4322\u20134328.", "journal-title": "Blood"}, {"key": "BFleu201047_CR22", "doi-asserted-by": "publisher", "first-page": "2434", "DOI": "10.1182/blood.V97.8.2434", "volume": "97", "author": "Y Yamamoto", "year": "2001", "unstructured": "Yamamoto Y, Kiyoi H, Nakano Y, Suzuki R, Kodera Y, Miyawaki S et al. Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood 2001; 97: 2434\u20132439.", "journal-title": "Blood"}, {"key": "BFleu201047_CR23", "doi-asserted-by": "publisher", "first-page": "1447", "DOI": "10.1038/sj.leu.2400756", "volume": "11", "author": "H Kiyoi", "year": "1997", "unstructured": "Kiyoi H, Naoe T, Yokota S, Nakao M, Minami S, Kuriyama K et al. Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho). Leukemia 1997; 11: 1447\u20131452.", "journal-title": "Leukemia"}, {"key": "BFleu201047_CR24", "doi-asserted-by": "publisher", "first-page": "31", "DOI": "10.1038/sj.thj.6200216", "volume": "4", "author": "S Barjesteh van Waalwijk van Doorn-Kh", "year": "2003", "unstructured": "Barjesteh van Waalwijk van Doorn-Khosrovani S, Erpelinck C, Meijer J, van Oosterhoud S, van Putten WL, Valk PJ et al. Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML. Hematol J 2003; 4: 31\u201340.", "journal-title": "Hematol J"}, {"key": "BFleu201047_CR25", "doi-asserted-by": "publisher", "first-page": "262", "DOI": "10.1038/leu.2008.313", "volume": "23", "author": "IH Hollink", "year": "2009", "unstructured": "Hollink IH, Zwaan CM, Zimmermann M, Arentsen-Peters TC, Pieters R, Cloos J et al. Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML. Leukemia 2009; 23: 262\u2013270.", "journal-title": "Leukemia"}, {"key": "BFleu201047_CR26", "first-page": "1512", "volume": "112", "author": "BV Balgobind", "year": "2008", "unstructured": "Balgobind BV, Hollink IHIM, Reinhardt D, van Wering ER, de Graaf SSN, Baruchel A et al. Low frequency of MLL-PTD detected in pediatric acute myeloid leukemia using MLPA screening. ASH Annual Meet Abstr 2008; 112: 1512.", "journal-title": "ASH Annual Meet Abstr"}, {"key": "BFleu201047_CR27", "unstructured": "Irizarry RA, Gautier L, Bolstad BM, Miller C, Astrand M, Cope LM et al. Affy: methods for affymetrix oligonucleotide arrays. Part of Bioconducter, \n                    http://www.bioconducter.org\n                    \n                  ."}, {"issue": "Suppl 1", "key": "BFleu201047_CR28", "doi-asserted-by": "publisher", "first-page": "S96", "DOI": "10.1093/bioinformatics/18.suppl_1.S96", "volume": "18", "author": "W Huber", "year": "2002", "unstructured": "Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M . Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics (Oxford, England) 2002; 18 (Suppl 1): S96\u2013S104.", "journal-title": "Bioinformatics (Oxford, England)"}, {"key": "BFleu201047_CR29", "unstructured": "Team RDC. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2007."}, {"key": "BFleu201047_CR30", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.2202/1544-6115.1027", "volume": "3", "author": "G Smyth", "year": "2004", "unstructured": "Smyth G . Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: 1.", "journal-title": "Stat Appl Genet Mol Biol"}, {"key": "BFleu201047_CR31", "first-page": "289", "volume": "57", "author": "Y Benjamini", "year": "1995", "unstructured": "Benjamini Y, Hochberg Y . Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B Met 1995; 57: 289\u2013300.", "journal-title": "J Royal Stat Soc B Met"}, {"key": "BFleu201047_CR32", "doi-asserted-by": "publisher", "first-page": "55", "DOI": "10.1016/S1525-1578(10)60652-6", "volume": "3", "author": "J Meijerink", "year": "2001", "unstructured": "Meijerink J, Mandigers C, van de Locht L, Tonnissen E, Goodsaid F, Raemaekers J . A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR. J Mol Diagn 2001; 3: 55\u201361.", "journal-title": "J Mol Diagn"}, {"key": "BFleu201047_CR33", "doi-asserted-by": "publisher", "first-page": "3938", "DOI": "10.1128/MCB.14.6.3938", "volume": "14", "author": "Q Lu", "year": "1994", "unstructured": "Lu Q, Wright DD, Kamps MP . Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation. Mol Cell Biol 1994; 14: 3938\u20133948.", "journal-title": "Mol Cell Biol"}, {"key": "BFleu201047_CR34", "doi-asserted-by": "publisher", "first-page": "3323", "DOI": "10.1182/blood-2008-06-162248", "volume": "113", "author": "YH Kuo", "year": "2009", "unstructured": "Kuo YH, Zaidi SK, Gornostaeva S, Komori T, Stein GS, Castilla LH . Runx2 induces acute myeloid leukemia in cooperation with Cbfbeta-SMMHC in mice. Blood 2009; 113: 3323\u20133332.", "journal-title": "Blood"}, {"key": "BFleu201047_CR35", "doi-asserted-by": "publisher", "first-page": "141", "DOI": "10.1016/j.bcmd.2007.07.012", "volume": "40", "author": "L Laricchia-Robbio", "year": "2008", "unstructured": "Laricchia-Robbio L, Nucifora G . Significant increase of self-renewal in hematopoietic cells after forced expression of EVI1. Blood Cells Mol Dis 2008; 40: 141\u2013147.", "journal-title": "Blood Cells Mol Dis"}, {"key": "BFleu201047_CR36", "first-page": "601", "volume": "10", "author": "A Kilbey", "year": "1999", "unstructured": "Kilbey A, Stephens V, Bartholomew C . Loss of cell cycle control by deregulation of cyclin-dependent kinase 2 kinase activity in Evi-1 transformed fibroblasts. Cell Growth Differ 1999; 10: 601\u2013610.", "journal-title": "Cell Growth Differ"}, {"key": "BFleu201047_CR37", "doi-asserted-by": "publisher", "first-page": "4641", "DOI": "10.1182/blood-2006-10-051342", "volume": "109", "author": "H Hasle", "year": "2007", "unstructured": "Hasle H, Alonzo TA, Auvrignon A, Behar C, Chang M, Creutzig U et al. Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study. Blood 2007; 109: 4641\u20134647.", "journal-title": "Blood"}, {"key": "BFleu201047_CR38", "doi-asserted-by": "publisher", "first-page": "17", "DOI": "10.1002/pbc.20951", "volume": "49", "author": "DR Barnard", "year": "2007", "unstructured": "Barnard DR, Alonzo TA, Gerbing RB, Lange B, Woods WG . Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group. Pediatr Blood Cancer 2007; 49: 17\u201322.", "journal-title": "Pediatr Blood Cancer"}, {"key": "BFleu201047_CR39", "doi-asserted-by": "publisher", "first-page": "1532", "DOI": "10.1182/blood-2002-02-0492", "volume": "100", "author": "DG Gilliland", "year": "2002", "unstructured": "Gilliland DG, Griffin JD . The roles of FLT3 in hematopoiesis and leukemia. Blood 2002; 100: 1532\u20131542.", "journal-title": "Blood"}, {"key": "BFleu201047_CR40", "doi-asserted-by": "publisher", "first-page": "1536", "DOI": "10.1038/sj.leu.2403870", "volume": "19", "author": "BF Goemans", "year": "2005", "unstructured": "Goemans BF, Zwaan CM, Miller M, Zimmermann M, Harlow A, Meshinchi S et al. Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia. Leukemia 2005; 19: 1536\u20131542.", "journal-title": "Leukemia"}, {"key": "BFleu201047_CR41", "doi-asserted-by": "publisher", "first-page": "432", "DOI": "10.1016/j.ccr.2008.03.005", "volume": "13", "author": "W Chen", "year": "2008", "unstructured": "Chen W, Kumar AR, Hudson WA, Li Q, Wu B, Staggs RA et al. Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells. Cancer Cell 2008; 13: 432\u2013440.", "journal-title": "Cancer Cell"}, {"key": "BFleu201047_CR42", "doi-asserted-by": "publisher", "first-page": "3872", "DOI": "10.1182/blood-2002-10-3243", "volume": "101", "author": "H Tonnies", "year": "2003", "unstructured": "Tonnies H, Huber S, Kuhl JS, Gerlach A, Ebell W, Neitzel H . Clonal chromosomal aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor. Blood 2003; 101: 3872\u20133874.", "journal-title": "Blood"}, {"key": "BFleu201047_CR43", "doi-asserted-by": "publisher", "first-page": "2489", "DOI": "10.1182/blood-2009-04-215152", "volume": "114", "author": "BV Balgobind", "year": "2009", "unstructured": "Balgobind BV, Raimondi SC, Harbott J, Zimmermann M, Alonzo TA, Auvrignon A et al. Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study. Blood 2009; 114: 2489\u20132496.", "journal-title": "Blood"}, {"key": "BFleu201047_CR44", "doi-asserted-by": "publisher", "first-page": "7658", "DOI": "10.1128/MCB.00363-06", "volume": "26", "author": "L Laricchia-Robbio", "year": "2006", "unstructured": "Laricchia-Robbio L, Fazzina R, Li D, Rinaldi CR, Sinha KK, Chakraborty S et al. Point mutations in two EVI1 Zn fingers abolish EVI1-GATA1 interaction and allow erythroid differentiation of murine bone marrow cells. Mol Cell Biol 2006; 26: 7658\u20137666.", "journal-title": "Mol Cell Biol"}, {"key": "BFleu201047_CR45", "doi-asserted-by": "publisher", "first-page": "6454", "DOI": "10.1073/pnas.90.14.6454", "volume": "90", "author": "BL Kreider", "year": "1993", "unstructured": "Kreider BL, Orkin SH, Ihle JN . Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene. Proc Natl Acad Sci USA 1993; 90: 6454\u20136458.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFleu201047_CR46", "doi-asserted-by": "publisher", "first-page": "609", "DOI": "10.1006/bbrc.2002.6693", "volume": "292", "author": "S Shimizu", "year": "2002", "unstructured": "Shimizu S, Nagasawa T, Katoh O, Komatsu N, Yokota J, Morishita K . EVI1 is expressed in megakaryocyte cell lineage and enforced expression of EVI1 in UT-7/GM cells induces megakaryocyte differentiation. Biochem Biophys Res Commun 2002; 292: 609\u2013616.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "BFleu201047_CR47", "doi-asserted-by": "publisher", "first-page": "1876", "DOI": "10.1038/sj.leu.2401887", "volume": "14", "author": "D Louz", "year": "2000", "unstructured": "Louz D, van den Broek M, Verbakel S, Vankan Y, van Lom K, Joosten M et al. Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice. Leukemia 2000; 14: 1876\u20131884.", "journal-title": "Leukemia"}, {"key": "BFleu201047_CR48", "doi-asserted-by": "publisher", "first-page": "1617", "DOI": "10.1056/NEJMoa040465", "volume": "350", "author": "PJ Valk", "year": "2004", "unstructured": "Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004; 350: 1617\u20131628.", "journal-title": "N Engl J Med"}, {"key": "BFleu201047_CR49", "first-page": "757", "volume": "112", "author": "S Lugthart", "year": "2008", "unstructured": "Lugthart S, Figueroa ME, Valk PJM, Li Y, Erpelinck-Verschueren C, Greally J et al. Two different EVI1 expressing poor-risk AML subgroups with Distinct epigenetic signatures uncovered by genome wide DNA methylation profiling. ASH Annual Meet Abstr 2008; 112: 757.", "journal-title": "ASH Annual Meet Abstr"}, {"key": "BFleu201047_CR50", "doi-asserted-by": "publisher", "first-page": "4364", "DOI": "10.1038/onc.2009.288", "volume": "28", "author": "M Shimabe", "year": "2009", "unstructured": "Shimabe M, Goyama S, Watanabe-Okochi N, Yoshimi A, Ichikawa M, Imai Y et al. Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells. Oncogene 2009; 28: 4364\u20134374.", "journal-title": "Oncogene"}], "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/leu201047.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/leu201047", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/leu201047.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 15]], "date-time": "2019-05-15T06:05:55Z", "timestamp": 1557900355000}, "score": 26.459972, "issued": {"date-parts": [[2010, 4, 1]]}, "references-count": 50, "journal-issue": {"published-print": {"date-parts": [[2010, 5]]}, "issue": "5"}, "alternative-id": ["BFleu201047"], "URL": "http://dx.doi.org/10.1038/leu.2010.47", "relation": {"cites": []}, "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}